rfhg_81529.1

Basic information about the TSS

---

TSS ID: rfhg_81529.1 Species: human Chr: chr6		Start: 33313695 End: 33313760 Strand: -
Source datasets	PRJNA4843412|DRA013844
Protocol	NETCAGE|CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3833075,EH38E2460554)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000476333.1:-195 GeneID: 6892 HGNC/MGI_ID: HGNC:11566 UniProt_ID: Nearer transcript ids and distances: ENST00000437116.2:-281 EU693375:-281 AF314222:-281 HQ447577:-282 CU687344:-282 ENST00000480730.5:-289 AF067286:-289 AB010639:-294 AF009510:-297 ENST00000434618.7:-318 NM_003190.5:-318 NM_172209.3:-318 NM_172208.3:-318 AF029750:-319 LF341208:-346 MA576785:-346 Y13582:-410 ENST00000426633.6:-452 BC010279:-452 BC080574:-452 ENST00000467025.1:-455 BC064966:-484 ENST00000475304.5:-491 ENST00000489157.5:-494 AK297903:-494 view more...

Gene_name: TAP binding protein Gene_symbol: TAPBP Gene_synonyms: TAPA Gene_source: HGNC:11566

TATA-Box annotation

---

Distance to TSS:	351
Nearest PromoterID:	NM_172209
Entrez ID:	6892
Nearest Unigene:	Hs.370937
Nearest Refseq:	NM_003190
Nearest Ensembl:	ENSG00000231925
Gene Name:	TAP binding protein
Gene Alias:	NGS17|TAPA|TPN|TPSN
Gene Type:	protein-coding
CpG%:	0.107692
GC%:	0.712121
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TAPBP p2@TAPBP p3@TAPBP p4@TAPBP p5@TAPBP p6@TAPBP p7@TAPBP p8@TAPBP p9@TAPBP
Sample		p1@TAPBP	p2@TAPBP	p3@TAPBP	p4@TAPBP	p5@TAPBP	p6@TAPBP	p7@TAPBP	p8@TAPBP	p9@TAPBP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.45	1.75	0.58	0.39	0.39	0.00	2.92	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	3.64	1.21	0.40	0.81	0.40	0.20	2.63	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.40	2.12	1.16	0.39	0.19	0.00	3.47	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.78	1.25	0.62	0.42	0.42	0.21	3.12	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.52	1.57	0.90	0.00	0.90	0.45	4.27	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.78	1.16	0.39	0.78	1.16	0.58	4.65	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	18.30	1.74	0.44	0.44	1.31	0.44	3.92	1.09	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.99	2.66	0.97	0.00	1.70	0.48	4.60	0.73	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.68	2.78	0.64	1.50	0.64	0.64	1.92	0.64	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.71	1.74	1.16	0.00	4.64	2.90	15.65	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.47	1.62	0.81	1.62	2.02	1.62	12.53	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	26.83	0.41	0.41	0.41	0.81	2.03	12.60	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	54.32	13.06	5.64	1.61	2.10	0.64	0.48	0.64	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	53.52	10.52	8.72	0.60	2.71	0.75	0.15	0.60	3.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	37.10	7.46	3.95	1.32	3.07	0.44	0.00	0.44	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	44.51	9.31	4.78	1.51	1.51	0.75	0.00	1.01	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	44.34	9.61	5.46	1.97	2.84	1.09	0.00	0.44	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	52.73	7.59	5.06	1.27	2.11	0.00	0.00	0.42	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.39	6.40	4.80	1.60	2.67	2.13	1.07	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.88	9.48	5.87	0.90	2.11	1.35	0.15	0.15	3.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	49.58	12.30	5.88	1.47	1.20	0.80	0.80	0.94	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	53.51	11.39	5.87	0.69	3.63	1.55	0.00	0.17	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	48.08	7.37	5.69	1.03	2.97	1.42	0.90	0.39	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	39.07	8.25	5.82	0.97	2.43	0.97	0.49	0.97	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	47.99	6.19	5.42	1.55	1.29	2.06	1.29	0.77	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	47.79	6.96	5.38	1.27	1.58	1.27	0.95	1.58	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	50.00	6.04	6.04	2.75	1.10	2.20	0.00	0.00	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	75.68	13.44	4.95	2.12	3.06	2.12	1.89	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	58.31	7.43	4.68	0.97	3.39	1.13	0.81	0.65	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	52.48	10.32	6.15	1.81	3.08	1.81	1.27	0.90	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	69.08	7.75	3.35	1.47	2.72	1.88	1.05	1.47	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	69.95	7.62	4.49	1.37	2.93	2.54	0.00	1.17	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	91.38	11.18	4.22	1.69	2.95	1.48	1.06	0.63	5.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	84.61	8.08	5.44	0.49	5.28	3.79	1.15	1.48	5.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	81.90	8.79	3.74	2.24	2.99	2.43	1.12	1.31	4.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	78.76	7.28	3.64	1.72	2.68	2.68	0.96	0.57	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	94.22	10.63	5.52	1.43	3.88	2.04	0.82	0.61	4.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	88.45	9.07	5.24	1.81	3.02	1.41	1.21	0.81	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	74.82	8.37	5.13	2.43	2.70	2.43	0.81	1.08	4.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	89.54	7.20	4.56	0.72	3.12	2.16	0.96	0.00	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	101.63	8.00	6.59	1.18	3.06	1.88	0.00	1.18	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	106.28	8.20	3.51	0.88	3.22	2.05	1.02	1.76	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	110.30	10.97	4.85	1.27	4.85	4.01	0.21	0.63	5.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	119.76	8.39	3.32	2.45	5.07	3.32	0.17	0.87	5.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	110.22	7.63	5.02	2.01	5.62	1.41	0.40	1.61	4.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	125.86	7.21	3.95	2.09	4.19	2.56	0.47	1.63	4.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	125.23	8.64	5.52	2.16	4.08	2.64	0.24	0.72	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	126.97	7.15	2.98	1.49	2.98	2.98	0.60	2.68	4.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	157.75	8.14	8.62	1.20	4.31	2.39	0.72	0.96	6.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	154.48	6.27	4.45	2.43	7.48	2.22	0.40	1.42	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	175.24	5.53	5.33	0.82	6.97	2.05	0.41	1.23	12.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	194.80	7.56	4.23	1.33	5.78	2.45	1.11	1.78	13.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	41.98	13.99	0.00	13.99	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	160.75	4.26	5.68	2.84	5.32	3.19	0.00	0.00	7.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	175.63	7.62	2.98	1.66	5.96	2.98	0.33	0.66	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	90.61	8.39	5.87	0.00	5.87	2.52	0.00	0.00	10.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	129.97	6.89	1.38	1.84	5.51	1.84	0.00	1.38	15.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	174.69	3.89	1.30	1.62	8.10	0.97	0.32	1.30	5.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	164.12	6.10	3.21	0.96	8.35	2.57	0.64	0.32	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	160.31	6.60	2.83	1.89	5.97	3.14	0.31	1.26	15.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	250.29	4.94	2.12	1.41	7.05	2.12	0.00	0.00	6.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	198.52	3.36	3.36	2.80	6.73	2.24	0.00	1.12	10.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	223.72	1.59	2.39	0.80	13.53	1.59	0.80	0.80	31.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	233.08	2.38	2.04	0.00	6.80	2.38	0.34	0.68	31.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	263.84	4.22	2.27	1.95	9.10	3.57	0.00	1.30	16.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	300.31	3.19	1.77	1.06	7.81	1.77	0.00	1.42	24.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	113.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	118.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	39.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	366.61	4.88	2.44	2.44	10.24	2.44	0.49	1.95	9.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	402.65	0.99	3.97	0.99	14.38	0.99	0.00	0.50	11.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	382.80	2.81	2.35	0.94	12.20	0.94	0.00	1.88	6.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	358.35	3.97	3.64	1.99	7.29	1.32	0.33	1.99	17.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	418.85	3.40	4.95	1.24	13.92	2.17	0.31	0.93	15.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	469.32	3.97	1.83	3.67	14.06	1.83	0.00	1.83	15.29
Adipocyte - breast, donor1	11376-118A8	32.47	6.81	5.54	1.74	1.27	0.95	0.16	0.63	0.63
Adipocyte - breast, donor2	11327-117E4	25.83	12.03	6.58	0.64	2.57	3.37	0.64	0.48	1.93
Adipocyte - omental, donor1	11473-119C6	25.06	6.74	4.33	1.27	1.27	1.15	0.38	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	18.69	7.47	2.99	0.75	2.24	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	21.77	8.37	2.01	0.67	1.67	1.34	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	10.21	12.12	1.28	0.00	1.28	0.00	0.64	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	17.59	4.40	3.30	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	35.23	8.13	9.03	1.35	0.00	1.35	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	28.50	7.30	3.48	0.35	0.52	0.35	0.17	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	89.18	13.30	8.41	1.56	1.96	1.37	0.98	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	90.85	12.87	5.15	1.80	1.29	1.54	2.83	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	102.59	15.61	11.99	3.90	2.23	1.67	0.84	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	87.58	8.82	4.70	1.18	1.76	2.35	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	48.66	11.90	8.45	1.93	1.85	2.01	0.72	0.48	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	140.08	12.91	10.01	2.26	1.61	1.29	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	58.65	11.20	5.87	1.60	0.53	3.73	1.07	0.00	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	26.15	9.46	6.68	2.78	1.67	2.23	1.67	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	29.94	12.48	8.32	2.91	3.74	7.90	0.00	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	105.99	12.81	9.54	4.02	3.52	2.51	0.75	0.75	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	39.92	15.71	7.20	1.31	3.60	3.27	0.00	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	16.44	6.70	2.44	1.83	0.91	6.09	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	28.95	13.26	9.94	5.52	1.10	0.44	0.88	1.10	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	42.31	27.97	10.76	4.66	0.72	2.15	0.36	1.43	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	29.95	11.98	9.58	1.20	0.00	2.40	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	47.32	19.25	14.93	9.36	1.26	0.72	0.00	1.44	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	31.80	20.08	20.08	13.39	0.00	0.00	0.00	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	46.23	28.56	23.01	8.42	1.23	1.64	0.21	4.52	1.03
Anulus Pulposus Cell, donor1	11248-116E6	40.16	19.68	16.94	6.41	0.92	1.37	0.00	1.49	0.80
Anulus Pulposus Cell, donor2	11463-119B5	25.96	18.12	14.45	7.84	0.24	0.98	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.67	9.44	5.84	5.84	1.80	1.80	0.00	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	24.31	12.59	10.42	4.34	1.74	2.17	0.43	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	10.70	2.14	4.28	2.14	2.14	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	29.89	8.37	10.76	3.59	1.79	0.90	1.20	0.60	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	29.09	12.65	8.85	2.53	2.53	1.26	0.00	1.26	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.14	9.24	9.24	3.30	0.00	2.64	0.66	2.64	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.34	12.35	8.12	2.60	0.97	1.95	0.00	1.95	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.24	10.68	9.22	1.94	2.43	0.49	0.00	3.40	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	10.69	6.53	2.38	0.59	2.38	0.00	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	21.09	11.30	8.29	3.39	1.13	1.13	2.26	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.75	10.16	5.81	7.26	1.45	1.45	0.73	5.08	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	3.76	0.00	2.51	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	35.58	9.06	8.40	5.11	0.66	1.81	0.66	0.99	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	8.19	8.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	20.06	7.39	6.18	2.56	0.15	0.90	0.30	1.06	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	29.47	7.50	6.97	3.75	0.54	0.00	0.54	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	26.83	14.93	10.96	4.16	1.89	2.08	0.38	2.83	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	27.00	6.95	8.29	3.47	1.60	2.41	0.27	0.27	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	31.21	9.75	5.85	5.85	0.00	0.98	0.98	4.88	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.70	14.60	12.44	4.15	0.17	1.66	0.17	1.99	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	26.42	1.20	7.20	2.40	1.20	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	14.16	7.08	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	33.96	12.86	12.35	3.77	0.69	1.20	1.37	2.06	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	4.19	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	23.79	5.83	9.71	3.40	1.46	0.97	1.46	0.97	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.11	18.97	9.49	5.69	0.38	2.28	0.38	2.28	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	2.42	3.63	4.85	1.21	0.00	2.42	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.95	14.25	6.84	2.28	0.57	0.00	1.14	2.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.07	15.18	11.97	4.28	0.86	0.86	1.07	2.57	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	25.81	8.00	9.29	2.58	1.29	1.03	0.77	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	23.93	11.26	6.57	1.41	0.94	1.88	0.47	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.94	11.90	8.68	2.89	0.32	0.96	0.32	1.61	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	9.27	3.57	0.71	0.71	1.43	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	4.09	8.19	2.92	0.58	1.17	1.17	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	29.20	14.15	10.24	3.91	1.20	1.20	0.60	2.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	10.69	4.75	4.75	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.38	11.70	10.17	5.59	2.03	3.05	0.51	3.05	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	23.94	12.73	10.70	2.55	0.25	1.53	0.76	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	18.43	5.08	10.17	1.27	1.91	0.64	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.83	11.65	8.20	5.18	1.29	2.16	1.73	3.45	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.98	10.37	8.26	2.54	1.06	1.27	0.21	2.12	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	21.75	8.70	7.25	3.77	0.87	0.29	0.29	1.45	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	5.67	12.28	6.61	1.89	0.00	0.94	0.94	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	22.38	11.87	10.34	3.39	0.51	1.19	1.02	1.70	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	11.58	2.32	0.00	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	12.68	6.34	8.45	0.00	0.00	4.23	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	32.16	9.43	9.86	4.72	0.43	1.93	0.43	0.86	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.87	8.42	9.02	1.20	0.00	4.21	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	22.60	10.93	5.10	2.19	0.73	1.46	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	36.55	14.48	11.49	4.60	0.69	1.38	1.38	2.30	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	15.30	12.75	2.55	2.55	2.55	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.63	8.39	2.80	1.53	0.25	2.03	0.00	0.25	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	47.07	10.53	12.80	5.57	2.89	1.65	1.24	2.68	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	31.52	7.96	8.26	2.14	0.92	3.06	1.22	1.53	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	39.68	10.52	7.17	3.82	2.87	3.35	0.96	2.87	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	48.78	13.08	8.43	5.99	2.22	2.00	0.67	1.33	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	4.58	7.63	1.53	1.53	1.53	0.00	0.00	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	37.11	8.86	11.08	3.88	0.55	1.66	0.00	2.77	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.31	9.80	10.59	3.44	0.79	1.59	1.06	1.59	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	37.07	4.72	7.63	1.45	0.36	0.73	0.36	1.09	0.73
Astrocyte - cerebellum, donor1	11500-119F6	87.69	27.76	14.86	5.16	0.86	0.37	0.49	0.98	0.37
Astrocyte - cerebellum, donor2	11580-120F5	67.78	29.78	11.81	4.28	1.03	1.03	0.00	0.68	0.17
Astrocyte - cerebellum, donor3	11661-122F5	77.19	19.72	8.60	3.36	0.84	0.42	0.42	1.68	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	40.44	15.69	9.06	3.14	1.05	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	31.06	12.78	6.47	1.62	0.81	0.65	0.16	0.81	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	33.56	14.62	6.56	1.64	0.60	0.30	0.45	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	355.53	2.64	1.26	0.46	4.24	0.92	0.00	0.46	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	340.52	1.50	0.75	0.13	3.88	0.75	0.00	0.38	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	297.69	3.07	1.14	0.34	1.93	0.57	0.11	0.68	1.02
Basophils, donor1	12241-129G9	195.63	4.18	3.14	0.26	2.09	0.52	0.78	0.26	0.78
Basophils, donor2	12242-129H1	171.38	4.33	2.53	0.72	2.53	2.89	0.36	0.36	0.00
Basophils, donor3	12243-129H2	262.10	4.12	2.79	1.76	2.94	1.03	1.62	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	39.46	17.46	17.90	7.76	1.72	0.65	0.86	4.10	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	118.87	39.32	26.06	11.43	2.29	1.83	1.37	5.03	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	50.21	14.35	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	17.57	5.65	1.88	0.63	1.88	0.00	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	30.57	24.33	16.22	8.73	2.50	1.46	0.00	2.91	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	18.88	15.20	11.05	5.53	0.69	1.38	0.46	0.92	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	20.15	19.25	12.42	3.24	0.00	1.44	0.54	1.26	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	142.22	4.43	2.37	0.31	1.34	0.82	0.00	0.10	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	175.14	1.86	0.23	0.00	1.63	0.00	0.00	0.23	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	225.12	6.40	2.56	0.32	2.24	0.96	0.00	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	279.23	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	193.30	4.51	5.07	0.56	3.38	0.56	2.25	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	251.49	4.27	2.97	1.11	4.83	1.11	1.30	0.19	0.93
CD14+ Monocytes, donor3	11381-118B4	201.97	5.49	1.54	1.32	3.07	0.88	2.85	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	223.32	8.21	3.68	1.42	7.36	1.13	0.00	0.00	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	327.14	9.10	7.20	3.03	5.69	1.52	0.38	0.38	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	307.37	11.83	5.92	1.64	6.90	0.99	0.00	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	212.20	2.60	3.18	1.01	6.65	0.43	1.01	0.14	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	130.05	3.02	1.21	0.60	3.62	0.00	1.21	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	197.09	1.90	1.42	0.95	7.58	0.95	2.37	0.24	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	176.44	2.51	1.67	0.84	4.18	0.67	3.01	0.00	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	133.04	0.83	0.55	0.28	3.31	0.28	3.59	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	160.66	2.73	1.98	0.99	4.96	0.99	8.43	0.25	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	196.39	1.96	1.76	0.98	3.13	0.98	4.31	0.59	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	181.97	2.67	1.25	0.89	4.81	0.18	3.38	0.00	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	181.72	2.18	1.74	1.31	5.22	1.09	4.79	0.00	1.96
CD14+ monocytes - treated with Candida, donor1	11868-125B5	154.29	2.11	1.87	0.00	3.51	0.47	7.02	0.23	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	129.89	1.06	1.06	0.53	2.11	0.00	7.92	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	113.15	2.22	2.22	0.00	2.22	1.11	11.09	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	202.15	2.53	3.12	1.34	5.35	0.30	2.38	0.30	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	126.31	2.00	1.80	0.40	3.59	0.40	2.99	0.20	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	122.21	1.46	1.46	1.04	2.29	0.62	6.04	0.42	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	213.91	2.29	3.43	1.14	4.80	0.92	8.24	0.46	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	174.63	2.04	1.36	0.68	3.62	0.45	9.95	0.23	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	156.25	1.31	2.18	0.00	3.49	0.00	12.22	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	222.99	2.15	1.61	1.08	5.65	1.34	0.54	0.27	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	194.35	2.79	1.92	0.70	5.58	0.70	1.40	0.00	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	242.81	3.37	1.68	0.84	9.68	2.52	4.21	0.00	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	234.60	2.76	2.76	1.10	5.14	0.92	11.02	0.73	2.02
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	172.26	3.87	1.41	1.06	6.69	2.47	13.03	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	215.41	2.19	3.51	1.75	7.02	2.19	16.67	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	182.05	2.44	2.27	0.17	3.66	1.05	2.27	0.17	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	161.68	2.97	1.86	0.37	2.60	1.49	1.12	0.00	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	191.19	2.37	1.94	0.43	4.74	0.43	7.11	0.00	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	210.48	2.05	2.05	2.05	5.73	1.23	9.01	0.82	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	167.59	3.25	0.70	1.39	2.32	0.70	13.91	0.23	1.62
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	171.44	2.09	2.09	0.70	6.03	0.70	13.22	1.39	1.62
CD14+CD16+ Monocytes, donor1	11789-124B7	93.51	0.87	0.87	0.87	2.18	1.09	0.22	0.00	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	189.42	2.08	1.62	0.23	2.08	0.00	0.00	0.23	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	77.98	1.30	1.08	0.43	2.17	0.65	0.22	0.00	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	156.03	3.74	1.56	0.93	2.96	0.62	0.31	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	194.90	2.97	2.27	0.70	2.45	0.70	0.17	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	170.57	2.68	1.56	0.89	3.12	1.56	0.00	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	71.96	0.26	0.26	0.26	1.28	0.00	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	108.90	1.98	0.88	0.44	1.54	0.22	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	62.95	0.42	0.42	0.21	1.26	0.21	0.21	0.00	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	294.68	2.03	2.03	2.03	6.10	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	320.01	4.07	1.36	0.68	3.39	2.03	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	338.64	2.07	3.11	0.00	4.14	1.04	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	283.58	2.67	1.07	1.07	2.67	3.20	0.00	0.53	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	326.47	1.07	0.54	1.61	8.58	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	351.67	3.51	4.21	1.40	6.32	0.70	0.00	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	346.68	1.57	0.78	1.57	2.35	1.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	366.48	1.32	2.64	0.00	6.59	3.95	0.00	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	429.03	0.00	1.64	0.82	4.93	3.29	0.00	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	470.08	0.73	1.45	0.00	6.53	2.90	0.00	1.45	2.90
CD19+ B Cells, donor3	11705-123B4	524.51	2.52	2.02	1.01	7.07	5.55	0.00	0.50	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	67.88	6.06	3.23	1.21	0.40	0.00	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	54.73	2.40	2.40	0.80	0.40	0.40	0.00	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	120.49	2.01	0.00	0.00	1.00	1.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	97.19	2.25	1.69	0.00	0.56	0.56	3.93	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	120.99	6.76	1.50	0.38	1.50	0.38	0.00	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	139.57	8.79	3.16	0.00	1.13	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	343.85	9.64	7.86	0.71	1.43	1.79	0.71	0.36	0.71
CD4+ T Cells, donor2	11306-117C1	410.90	11.02	3.67	1.84	7.35	4.29	1.22	0.61	6.74
CD4+ T Cells, donor3	11382-118B5	222.04	7.93	4.88	2.44	3.35	2.13	0.91	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	113.32	6.38	4.59	0.77	3.32	0.51	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	212.69	9.88	5.61	0.67	2.25	0.45	0.00	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	154.08	8.62	5.46	0.86	3.45	0.29	0.00	0.57	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	116.63	2.84	3.32	2.37	1.42	0.47	0.47	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	206.48	8.43	5.62	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	138.44	3.30	3.30	6.59	3.30	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	166.19	9.25	5.93	3.76	5.35	1.45	0.43	0.00	1.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	266.23	10.68	11.35	3.39	6.78	1.02	0.00	0.85	2.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	192.00	7.90	6.29	1.93	5.80	1.13	0.00	0.48	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	99.07	4.48	3.14	1.34	1.79	0.90	0.00	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	208.24	3.14	5.94	0.70	3.49	0.70	0.35	0.00	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	164.99	6.16	3.08	0.88	1.76	0.44	0.00	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	147.57	5.90	8.01	2.95	5.06	1.69	0.00	0.42	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	238.73	9.77	8.73	2.70	4.78	0.83	0.00	0.62	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	119.95	9.36	6.01	1.67	3.34	0.67	0.00	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	183.01	7.89	6.53	1.36	3.26	0.54	0.00	0.27	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	313.53	8.04	8.58	1.07	5.36	0.54	0.54	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	191.88	16.14	10.76	0.00	3.59	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	173.38	10.38	10.01	3.71	4.45	1.67	0.00	0.93	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	264.27	9.10	7.80	3.03	7.15	0.22	0.00	0.22	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	204.69	12.82	9.04	1.47	4.20	1.47	0.21	0.21	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	139.04	4.04	5.56	1.01	1.52	0.51	0.51	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	253.02	6.50	5.20	0.43	0.43	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	213.11	9.15	4.79	1.31	4.79	1.31	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	368.68	10.39	9.90	0.00	3.96	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	284.34	3.69	1.85	0.92	3.69	0.00	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	309.87	4.19	4.19	0.00	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	121.57	8.58	5.26	1.38	2.22	1.11	0.00	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	134.47	13.25	6.63	1.23	5.40	0.74	0.25	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	398.86	7.70	6.16	0.00	4.62	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	405.03	16.83	10.03	2.51	3.22	0.00	0.00	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	310.24	15.23	9.69	1.38	5.54	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	434.45	5.24	6.22	0.98	4.91	2.29	0.00	0.98	0.65
CD8+ T Cells, donor2	11307-117C2	424.24	13.52	7.51	0.75	10.89	2.25	0.00	1.13	4.13
CD8+ T Cells, donor3	11383-118B6	380.75	8.84	6.06	0.50	8.84	0.76	0.50	0.76	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	104.60	2.29	0.46	0.23	2.75	0.69	0.69	0.00	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	104.24	2.16	1.68	0.48	1.92	1.44	0.00	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	122.02	1.37	0.55	0.00	1.92	1.37	0.00	0.00	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	114.08	2.70	0.90	0.30	6.30	0.90	0.30	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	113.51	2.64	1.92	0.24	2.16	1.20	0.72	0.48	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	119.60	1.36	1.36	0.23	2.73	1.14	0.00	0.00	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	94.30	1.52	0.87	0.00	2.39	0.65	0.22	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	97.91	1.32	0.53	0.00	2.90	0.53	0.26	0.00	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	86.77	1.64	0.47	0.70	3.28	0.47	0.00	0.23	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	95.09	1.21	1.21	0.91	3.62	0.00	0.00	0.00	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	94.70	2.32	1.74	0.58	3.49	1.16	0.00	0.00	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	86.86	2.13	0.27	0.00	2.40	0.27	0.27	0.00	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	71.35	1.75	0.00	0.44	3.50	2.19	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	81.52	1.37	0.91	0.00	2.28	1.37	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	66.38	0.75	1.49	0.00	1.49	1.49	2.98	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	113.09	2.16	0.72	0.00	1.44	1.08	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	110.77	1.44	1.15	0.58	2.30	0.58	0.86	0.29	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	132.23	1.18	0.47	0.00	2.12	0.71	0.24	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	99.19	2.54	1.58	0.00	2.54	0.00	0.63	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	99.34	2.46	1.23	0.00	2.77	0.31	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	83.35	2.24	1.28	0.96	1.28	0.32	0.00	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	81.85	1.91	0.76	0.38	1.53	0.00	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	74.88	0.79	1.58	0.00	2.36	0.79	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	74.88	0.00	0.00	0.00	1.51	0.76	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	74.67	0.00	0.00	0.80	2.41	1.61	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	88.83	3.50	1.40	0.70	1.40	4.20	2.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	88.15	1.00	0.00	0.00	6.01	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	36.55	16.45	0.00	1.83	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	54.84	12.85	9.88	1.98	1.48	0.00	1.48	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	34.94	9.47	8.00	3.47	0.32	0.42	0.42	0.84	0.21
Chondrocyte - de diff, donor1	11261-116G1	20.80	14.21	10.05	1.04	0.35	1.39	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	28.79	9.24	4.62	1.42	0.36	0.36	0.36	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	28.90	8.99	6.26	1.82	0.80	1.02	1.02	0.68	0.34
Chondrocyte - re diff, donor2	11339-117F7	23.28	15.22	3.58	3.58	1.79	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	50.95	10.11	6.07	1.62	0.81	1.21	2.02	1.62	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	82.63	9.41	10.90	6.20	2.30	0.34	0.80	2.41	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	58.36	11.97	16.46	4.06	1.50	0.43	1.28	2.14	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	50.80	14.43	10.44	3.36	1.95	0.53	0.53	2.30	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	125.54	10.45	7.06	2.29	1.93	0.83	3.21	0.64	0.64
Corneal Epithelial Cells, donor1	11526-119I5	65.87	29.42	15.37	9.22	1.76	0.44	0.88	2.85	0.44
Corneal Epithelial Cells, donor2	11606-120I4	27.30	10.24	10.24	7.96	1.14	2.28	3.41	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	32.98	17.89	11.76	6.39	0.77	0.77	0.00	1.53	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	192.17	11.72	15.02	8.58	2.31	0.83	0.17	1.49	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	171.27	12.30	11.04	4.10	1.58	0.63	1.58	2.52	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	110.42	13.80	17.25	13.80	3.45	3.45	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	119.22	13.93	12.74	5.18	2.05	0.54	0.97	1.40	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	192.69	2.05	0.34	0.00	1.37	1.37	0.34	0.34	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	228.50	0.65	0.65	0.00	1.31	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	73.56	0.97	0.00	0.97	0.00	0.97	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	29.02	14.34	8.17	2.00	0.50	0.17	0.17	0.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	26.40	17.02	6.45	1.76	1.17	0.59	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	40.72	13.29	8.48	2.83	0.00	0.57	0.85	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	27.13	12.98	9.44	5.50	2.36	0.00	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	39.85	18.03	7.85	5.24	2.04	0.29	0.29	2.33	0.00
Endothelial Cells - Artery, donor2	11341-117F9	44.00	16.23	7.53	2.82	1.65	0.47	0.00	1.18	1.41
Endothelial Cells - Artery, donor3	11413-118E9	31.73	13.85	8.77	2.45	0.70	0.35	0.35	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	69.82	15.29	12.86	5.98	2.88	0.44	2.22	3.10	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	77.89	17.04	14.60	5.48	1.83	0.91	0.30	2.74	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	71.32	13.25	10.43	4.79	1.69	0.56	1.69	0.85	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	109.64	14.56	12.18	3.27	2.38	0.30	0.30	0.00	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	77.58	7.81	8.85	1.56	1.04	0.52	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	106.06	11.48	7.23	2.84	1.42	0.57	0.14	0.99	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	38.81	18.01	10.00	2.80	1.60	0.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	52.94	13.63	6.81	4.72	0.52	0.52	0.52	2.10	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	42.12	20.00	10.69	1.74	1.37	0.12	0.62	0.25	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	32.15	13.90	5.87	0.43	1.30	0.00	0.65	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	45.07	14.04	6.35	1.34	1.83	0.49	0.24	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	12.51	18.20	2.28	0.00	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	15.37	14.67	5.59	3.49	2.79	0.00	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	28.42	12.09	5.97	1.26	0.94	0.31	0.47	0.47	0.00
Eosinophils, donor1	12244-129H3	106.73	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	651.85	4.95	6.60	0.00	16.50	6.60	3.30	1.65	1.65
Eosinophils, donor3	12246-129H5	627.76	7.13	3.57	3.57	3.57	0.00	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	37.63	22.48	23.21	8.31	1.22	0.98	0.00	2.93	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	16.64	8.32	4.16	0.00	2.08	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	16.27	0.00	16.27	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.86	11.49	6.16	2.46	0.41	1.23	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.36	10.40	7.12	3.39	2.19	3.39	0.33	1.42	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.49	3.79	1.95	0.22	0.22	0.87	0.43	0.11	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.32	11.04	9.82	2.67	1.33	0.73	0.61	1.46	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	34.25	15.56	10.92	6.96	1.09	6.55	1.91	3.41	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	44.93	17.82	12.66	5.27	2.64	2.32	0.84	1.27	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	70.62	28.46	18.97	6.32	1.84	2.90	1.32	0.79	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	39.53	15.61	6.64	1.99	1.66	0.66	0.66	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	24.50	12.25	8.62	4.99	1.36	0.00	0.91	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	35.62	15.92	18.19	3.79	3.79	3.03	3.03	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	54.57	17.98	14.98	6.31	1.73	1.58	2.84	3.94	1.73
Fibroblast - Cardiac, donor4	11452-119A3	53.65	10.91	11.52	3.94	1.52	0.91	0.91	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	21.95	12.44	8.63	2.54	0.89	0.63	2.16	0.89	0.25
Fibroblast - Cardiac, donor6	11460-119B2	20.92	13.95	4.70	3.03	1.36	0.30	0.30	0.45	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	52.93	17.15	10.32	4.42	0.80	0.27	0.27	0.67	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	52.63	14.24	4.75	4.75	0.00	0.00	0.00	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	21.97	14.65	5.86	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	25.14	17.07	8.30	3.23	0.69	1.38	1.61	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	54.78	12.89	8.48	2.54	0.34	0.85	0.17	0.85	0.68
Fibroblast - Dermal, donor1	11269-116G9	22.77	10.10	10.57	4.23	2.11	2.82	0.70	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	19.34	14.62	6.13	3.30	0.00	1.42	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	29.98	12.93	10.64	3.87	1.33	3.38	0.85	0.60	0.60
Fibroblast - Dermal, donor4	11450-119A1	5.20	5.43	3.62	0.90	0.34	0.34	0.34	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	8.90	8.55	3.49	1.05	0.35	0.17	0.17	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	10.07	8.12	3.57	0.81	0.65	1.46	0.16	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	22.28	14.78	11.87	5.21	1.46	2.50	0.21	0.83	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.30	15.98	10.74	3.14	1.83	3.14	2.10	0.79	0.26
Fibroblast - Gingival, donor2	11318-117D4	22.27	14.63	6.98	2.77	0.53	2.24	0.53	0.26	0.26
Fibroblast - Gingival, donor3	11394-118C8	33.55	17.69	11.89	4.45	1.06	2.51	0.00	0.29	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	112.20	21.82	14.54	2.08	8.31	1.04	0.00	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	71.54	16.03	5.64	2.64	1.41	1.41	0.35	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.81	12.78	7.48	1.25	1.09	2.18	0.31	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.55	13.93	7.30	2.70	1.76	1.49	0.00	0.95	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	55.40	54.70	41.99	12.70	6.35	7.06	0.35	5.29	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	23.55	9.80	8.19	1.75	1.02	1.90	0.29	0.73	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	26.73	16.91	12.82	2.32	1.23	1.09	0.68	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.10	11.85	9.21	1.97	1.21	1.54	0.33	0.44	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.79	10.86	6.75	1.47	2.49	1.61	0.44	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	27.19	17.67	12.23	1.36	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	11.94	8.95	1.49	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	27.01	13.72	10.13	1.06	0.84	0.21	0.21	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	50.81	29.99	12.50	7.50	0.00	4.17	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	18.18	5.59	5.59	0.00	5.59	1.40	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	63.25	17.63	12.31	6.72	2.80	2.24	0.84	1.12	0.00
Fibroblast - Mammary, donor1	11540-120B1	48.31	19.89	17.86	7.31	1.22	1.22	0.00	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	67.90	7.99	11.98	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	29.78	17.87	11.91	5.96	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.55	8.34	6.21	2.91	0.58	0.00	0.00	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.02	12.59	8.65	1.37	0.46	0.15	0.00	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.01	15.91	15.30	5.81	0.92	4.28	0.00	1.53	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	24.81	18.70	9.54	4.58	0.38	1.91	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	24.57	17.01	10.53	1.62	0.27	1.62	0.27	1.08	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	77.12	21.92	10.21	2.78	2.09	0.70	0.12	0.81	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.15	7.74	7.30	3.43	0.22	0.11	0.33	1.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	85.34	35.76	33.32	17.27	1.22	1.83	1.02	3.25	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	51.45	12.03	7.35	4.01	1.34	2.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	46.26	11.47	7.12	3.95	1.19	0.40	0.40	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.49	18.85	11.51	1.59	0.20	2.78	1.98	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	23.98	8.35	4.97	1.95	0.36	0.89	0.89	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	28.97	11.04	8.08	4.93	0.39	1.18	0.59	0.59	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	16.55	18.95	13.84	3.91	0.30	3.61	1.81	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.19	14.25	7.45	3.02	0.43	0.97	2.16	0.32	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.43	15.44	6.07	3.54	1.01	2.02	2.78	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	22.31	13.62	6.56	2.79	0.49	0.82	1.31	0.66	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.85	18.05	15.04	4.21	1.20	4.41	0.80	1.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	6.83	12.76	6.63	2.91	0.50	2.01	0.90	1.21	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.67	12.69	8.46	2.12	0.60	3.63	1.51	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.28	8.04	5.05	1.74	0.25	1.16	0.83	0.66	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	37.95	10.43	8.72	1.71	1.20	0.68	1.54	0.68	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	27.59	30.54	19.71	4.93	0.66	4.93	1.97	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8.95	16.19	7.35	2.98	0.43	2.45	1.17	0.43	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	11.13	15.52	8.77	3.71	0.17	0.17	1.01	1.01	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	11.45	8.31	2.67	1.25	1.25	0.94	0.47	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	41.83	6.10	6.97	0.87	2.61	0.87	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	61.02	18.55	19.94	12.48	2.08	1.56	0.52	5.89	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	85.62	21.60	20.82	11.71	0.00	0.00	1.30	7.29	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	87.13	26.32	21.72	15.84	3.07	2.04	0.26	8.18	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	3.06	4.59	0.00	0.77	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3.83	3.19	5.74	0.00	0.64	0.00	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	7.70	5.71	1.14	0.29	0.29	0.00	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4.14	6.34	0.83	0.28	1.10	0.28	0.00	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1.83	3.65	1.14	0.91	0.91	0.00	0.00	0.46	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	8.52	5.35	1.39	0.20	1.39	0.00	0.00	0.00	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3.44	3.97	1.06	0.00	1.06	0.00	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2.94	3.59	0.98	0.00	0.00	0.00	0.00	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.00	13.71	2.65	0.44	0.00	0.44	0.00	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	16.68	13.99	4.80	1.13	0.57	0.57	0.14	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.49	11.21	4.06	1.72	0.49	0.62	0.00	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.94	7.25	2.95	1.34	0.81	0.00	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.76	15.12	4.96	1.98	1.49	0.12	0.62	0.87	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.79	14.40	4.29	1.11	0.83	0.00	0.28	0.83	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	28.06	8.34	3.46	1.22	1.22	0.00	0.41	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	40.16	11.64	5.93	2.74	0.91	0.00	0.91	1.14	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.38	12.95	4.73	1.99	0.75	0.25	0.37	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	39.34	10.49	6.99	2.62	1.53	0.44	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	37.53	8.27	3.55	1.77	0.59	0.00	1.18	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.18	13.35	3.34	2.07	0.95	0.32	0.48	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.31	14.08	5.81	1.79	1.34	0.00	0.45	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	36.70	9.07	4.23	1.41	0.40	0.00	0.00	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	28.67	7.97	2.04	1.02	0.51	0.68	0.51	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	44.96	9.75	5.68	2.66	1.24	0.53	0.44	0.62	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.79	16.86	6.04	2.50	1.46	0.42	0.21	0.42	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	57.89	14.17	5.29	0.34	1.37	0.34	0.00	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.45	10.40	2.43	0.77	0.77	0.44	0.55	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.36	9.32	6.24	2.08	0.42	0.33	0.67	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.08	8.17	5.10	0.61	0.61	0.41	0.41	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	33.42	8.46	3.92	0.21	0.21	0.00	0.21	0.41	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.71	12.34	3.57	1.38	0.58	0.35	0.35	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.19	10.67	4.00	1.50	0.83	0.33	0.17	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	31.52	11.02	2.87	0.66	0.66	0.22	0.66	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	33.45	12.30	2.09	0.74	0.61	0.12	0.49	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	30.31	7.13	4.54	0.97	0.65	0.16	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.90	17.00	5.45	3.53	1.28	0.64	0.96	1.60	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	29.18	10.52	3.51	1.61	0.47	0.19	0.57	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.79	9.02	2.69	0.79	0.79	0.16	0.32	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	42.27	17.03	6.08	1.22	0.30	0.00	0.30	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.90	9.83	2.82	1.05	0.63	0.63	0.31	0.52	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.49	11.20	2.42	1.54	1.10	0.66	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	46.85	13.47	6.17	1.12	1.12	0.28	0.56	0.84	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	32.41	10.09	2.78	0.74	0.74	0.56	0.09	0.09	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.73	8.29	2.14	0.80	0.53	0.80	0.53	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.46	9.64	4.59	1.38	1.22	0.31	0.15	0.31	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.24	12.82	3.11	1.30	0.39	0.13	0.39	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.65	11.66	5.96	1.36	1.08	0.54	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.74	11.06	5.90	1.29	0.18	0.37	0.37	0.18	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	31.58	9.21	4.17	0.66	0.66	0.00	0.44	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	65.46	10.91	8.93	1.98	0.99	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	38.78	10.68	6.46	1.19	0.92	0.66	0.40	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	53.87	13.11	4.44	0.40	1.21	0.81	0.00	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	118.69	30.75	15.50	3.30	1.27	0.76	0.00	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	32.05	13.34	5.37	0.60	0.40	0.20	0.00	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.56	14.95	3.39	2.00	1.23	0.00	0.00	0.77	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	24.14	16.98	4.30	1.02	0.41	0.00	0.00	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.01	4.38	1.88	0.63	0.63	0.00	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.70	3.11	1.13	0.28	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	7.38	2.31	2.31	0.46	0.46	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	7.42	0.00	0.00	0.00	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	4.64	4.64	2.32	0.39	0.00	0.00	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	16.04	1.60	0.00	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	5.22	3.48	0.00	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.21	3.58	0.65	1.30	0.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	5.35	4.53	0.82	0.82	0.00	0.00	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	6.43	1.12	1.40	0.56	0.00	0.00	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.82	3.27	0.98	0.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1.68	4.19	0.84	0.00	0.84	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	8.91	4.77	1.59	0.32	0.95	0.32	0.00	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.13	2.38	1.36	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	4.18	0.00	4.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.03	6.30	1.15	0.00	1.15	0.00	0.00	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.43	2.96	0.89	0.59	0.30	0.00	0.00	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3.39	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	10.77	3.73	1.24	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	4.37	2.76	1.61	0.46	0.23	0.00	0.23	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	5.27	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	7.69	1.54	0.77	0.38	0.38	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	6.19	4.24	1.63	0.00	0.33	0.33	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	1.34	0.00	1.34	1.34	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.80	4.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	9.93	5.14	1.37	0.34	1.03	0.00	0.34	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	2.48	2.48	2.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	7.08	3.77	1.89	0.00	0.47	0.00	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.90	2.41	1.81	1.21	0.60	0.00	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	9.66	3.05	2.03	0.51	0.51	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	14.36	5.58	1.99	0.80	0.80	0.00	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.33	5.92	2.47	0.49	2.47	0.49	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	7.08	4.72	1.18	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.84	4.08	0.58	0.58	0.58	0.00	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	14.04	3.95	1.76	0.44	0.44	0.00	0.44	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	6.78	0.00	0.85	0.85	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	7.76	1.79	0.60	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.28	3.40	0.49	0.49	0.49	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	131.25	28.53	17.12	6.85	4.57	1.14	0.00	5.71	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	135.97	18.71	16.22	10.40	1.25	0.83	0.42	4.16	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	43.85	14.62	10.12	10.12	1.12	1.12	2.25	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	49.79	11.73	7.93	3.17	1.59	0.95	0.32	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	33.84	16.71	14.20	7.94	0.84	1.67	0.00	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	23.32	30.29	20.42	6.85	1.62	2.32	0.23	2.09	1.16
Hep-2 cells mock treated, biol_rep2	11899-125E9	25.32	33.25	19.07	7.09	1.35	1.18	0.68	1.35	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	25.03	34.13	16.15	7.05	0.91	1.14	0.00	2.05	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	25.25	27.66	20.99	7.00	0.66	0.87	0.33	1.86	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	23.86	29.44	21.71	6.02	2.79	2.15	0.64	1.29	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	21.74	26.69	21.31	7.10	0.43	0.43	0.22	1.72	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	23.91	28.15	21.30	7.22	0.87	0.62	0.75	2.37	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.90	22.99	16.30	4.97	0.69	0.86	0.17	1.20	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.71	22.11	14.74	4.49	0.96	0.32	0.96	2.88	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	58.20	17.35	7.83	6.16	2.24	0.56	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	52.80	16.88	10.39	4.76	1.73	0.43	0.87	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	13.22	5.29	10.58	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	40.92	11.64	14.46	6.70	1.06	0.71	1.76	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	44.32	23.25	18.89	5.81	2.91	2.91	0.00	3.63	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	16.61	11.36	9.27	2.97	0.35	0.70	0.00	0.17	0.35
Hepatocyte, donor1	11523-119I2	130.75	13.32	8.47	3.63	12.11	2.42	1.21	0.00	3.63
Hepatocyte, donor2	11603-120I1	135.74	12.93	10.77	1.08	6.46	1.08	0.00	0.00	4.31
Hepatocyte, donor3	11684-122I1	93.87	17.79	6.14	4.29	6.14	0.61	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	87.46	12.40	2.61	0.00	3.26	0.65	0.00	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	67.64	5.59	4.72	1.40	2.97	0.52	0.52	0.70	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	46.10	17.01	10.15	4.39	0.41	0.41	0.41	2.33	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	15.92	19.10	6.37	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	26.70	20.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	13.84	11.08	1.38	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	20.02	15.02	0.00	7.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	23.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	17.94	10.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	13.71	36.57	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	21.12	19.49	1.62	1.62	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	11.67	10.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	18.15	10.89	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	18.53	7.94	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	9.98	8.87	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	10.48	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	21.42	8.19	1.26	0.00	0.00	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	15.47	6.19	0.00	1.55	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	19.38	19.38	12.27	1.94	1.29	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	22.54	12.88	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	16.30	10.59	0.00	0.00	0.00	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	12.59	18.05	9.66	2.52	0.42	0.00	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	15.27	16.07	8.04	0.80	0.80	0.80	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.93	15.70	9.23	2.77	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	9.44	11.80	4.72	2.36	1.42	0.47	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	9.98	4.53	0.00	1.81	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	30.13	11.84	0.00	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	17.79	7.62	3.81	1.27	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.77	21.68	11.48	3.83	0.64	1.28	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	32.81	5.47	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	18.57	18.57	10.71	4.28	1.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	26.55	3.32	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.88	18.83	8.64	1.23	0.62	0.00	0.31	0.93	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	10.54	8.78	3.51	0.00	0.00	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	18.86	9.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.17	18.08	9.74	0.70	0.00	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	22.13	13.28	4.43	0.00	0.00	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	22.69	9.73	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	23.54	13.95	0.87	0.87	0.00	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	20.25	6.75	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	24.39	17.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	36.27	8.53	2.13	1.07	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	29.09	8.31	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	5.70	8.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	24.85	23.01	8.28	2.76	2.76	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	30.25	27.23	0.00	0.00	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	37.25	24.83	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	22.20	22.20	4.23	1.06	4.23	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	21.38	24.48	28.15	18.03	1.06	3.43	0.90	6.61	0.49
Keratinocyte - epidermal, donor2	11349-117G8	22.25	16.40	18.74	7.03	0.00	0.59	2.34	2.34	0.00
Keratinocyte - epidermal, donor3	11421-118F8	30.95	18.46	18.08	5.30	0.85	0.95	0.28	2.18	0.38
Keratinocyte - oral, donor1	11251-116E9	87.75	30.20	25.77	11.12	1.70	0.34	0.57	4.09	1.25
Keratocytes, donor1	11527-119I6	22.69	16.85	9.97	2.06	0.34	1.72	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	11.72	12.89	11.72	2.34	1.17	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	32.60	9.88	4.15	1.19	0.59	0.59	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	17.58	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	35.60	12.94	7.55	3.24	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	105.18	24.22	12.11	3.46	0.46	0.23	0.23	2.54	0.69
Lens Epithelial Cells, donor3	11690-122I7	94.96	16.75	13.32	6.66	1.21	1.01	0.20	3.23	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	271.66	6.17	5.22	2.37	3.68	0.36	0.59	0.95	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	94.05	2.23	1.67	1.40	2.51	0.84	0.00	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	114.12	4.25	2.99	0.63	3.94	0.31	0.94	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	154.86	4.84	3.23	2.15	1.61	0.00	0.54	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	104.32	1.89	3.78	1.26	1.58	0.32	0.00	0.63	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	108.78	3.67	3.13	1.19	2.80	1.08	0.32	1.08	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	171.95	4.51	1.64	0.82	1.23	0.41	0.41	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	117.06	2.78	3.03	1.26	1.01	0.76	0.00	1.52	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	115.70	5.07	4.22	1.41	3.24	0.99	0.42	0.28	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	170.87	2.77	2.37	1.98	0.40	0.79	0.00	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	116.33	1.36	3.30	0.58	3.10	0.58	0.19	0.58	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	104.61	4.07	3.33	0.93	2.41	0.00	0.19	1.11	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	186.76	2.44	3.14	0.70	2.44	1.05	0.70	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	124.03	1.91	1.43	1.91	4.29	0.48	0.48	1.19	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	110.84	3.98	2.88	1.10	2.61	0.41	0.96	0.55	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	196.48	3.39	1.23	1.54	3.70	1.23	0.31	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	103.81	2.18	1.56	1.25	0.62	0.00	0.31	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	129.01	4.94	5.31	0.73	3.48	0.55	0.73	0.55	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	189.90	2.96	3.62	1.32	1.65	0.99	0.99	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	123.59	2.34	1.76	0.88	2.93	0.59	0.59	0.88	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	121.98	2.49	4.48	0.25	2.49	0.50	0.50	0.50	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	163.92	6.30	1.94	0.00	4.36	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	107.18	1.62	3.23	1.62	0.27	0.00	0.54	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	104.00	4.84	2.27	1.06	3.33	0.91	0.91	2.12	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	177.82	3.63	2.07	1.04	1.56	1.04	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	115.37	2.09	0.84	1.88	2.93	0.84	0.63	0.63	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	124.66	4.66	3.16	0.30	3.61	0.60	0.30	1.05	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	167.84	2.75	6.88	1.38	0.69	0.00	0.69	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	104.80	1.69	2.63	0.56	0.94	1.13	0.94	0.56	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	138.16	3.92	3.29	2.01	3.71	0.11	1.17	0.53	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	171.06	2.91	1.45	1.94	3.39	0.48	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	110.15	2.32	1.32	0.00	4.30	0.00	1.32	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	132.94	3.72	3.35	0.37	3.72	0.25	0.74	0.87	1.36
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	199.17	6.66	3.70	1.48	2.96	0.00	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	97.35	1.24	1.98	1.24	0.99	0.74	0.49	0.99	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	124.02	3.30	3.85	0.96	3.16	0.41	1.10	0.14	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	165.64	2.89	3.86	1.29	1.93	0.64	0.32	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	123.86	0.61	1.22	0.30	2.74	0.61	0.61	0.91	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	115.61	3.50	2.80	2.10	3.64	0.84	0.56	0.14	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	163.20	3.56	3.56	1.07	2.13	0.36	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	98.41	0.48	2.91	0.48	1.45	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	143.94	2.96	2.02	0.31	4.36	0.47	0.78	0.62	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	164.01	2.86	1.79	1.43	1.07	0.36	0.36	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	107.48	1.96	2.29	0.98	3.27	0.98	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	115.59	4.47	3.06	0.94	3.53	0.47	0.24	0.47	2.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	287.97	6.19	4.83	1.86	3.84	0.87	0.87	0.74	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	112.95	1.28	2.31	2.82	2.05	0.26	0.00	0.51	1.28
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	99.65	3.58	1.49	0.90	3.88	0.90	0.90	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	52.12	13.60	9.06	2.27	4.53	2.27	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	94.36	16.11	11.51	3.07	1.53	1.53	0.00	3.07	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	79.42	12.62	8.16	2.97	0.74	2.23	0.00	2.23	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	103.24	12.69	8.46	2.54	2.12	2.12	0.85	2.12	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	109.02	13.36	11.96	4.22	2.11	2.81	1.41	0.00	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	91.53	14.94	8.41	1.87	1.87	0.00	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	78.84	10.82	10.31	5.15	4.12	2.06	0.00	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	78.50	20.22	10.71	2.38	1.19	1.19	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	84.60	16.74	11.31	4.07	1.58	1.13	0.23	1.58	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	72.13	13.67	6.98	2.91	2.62	0.58	0.87	0.58	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	71.58	9.45	10.80	2.25	1.35	0.45	0.45	1.80	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	133.18	18.29	16.53	5.96	2.71	0.81	0.68	2.30	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	94.49	11.30	9.76	4.62	2.57	0.51	0.00	2.05	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	74.81	14.82	8.82	2.82	1.76	1.06	1.06	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	63.97	6.66	9.33	2.00	2.67	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	68.26	17.32	9.17	3.06	0.51	1.02	1.53	1.02	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	85.11	10.94	13.87	2.40	1.60	0.80	1.33	1.07	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	82.76	16.44	11.71	3.59	1.89	0.57	1.32	2.08	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	87.74	14.73	11.04	5.52	1.84	1.84	0.61	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	89.70	22.02	15.49	7.34	5.71	0.00	1.63	3.26	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	94.54	15.20	7.50	2.92	2.92	0.42	1.04	2.92	2.71
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	79.31	13.73	9.53	3.36	1.96	0.56	0.56	1.12	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	96.85	23.70	7.21	4.12	1.03	0.00	1.03	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	78.96	15.39	10.16	2.61	6.39	0.29	0.29	2.61	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	72.34	9.86	7.47	2.39	2.09	0.60	0.30	0.90	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	79.12	9.96	11.07	2.21	3.32	0.55	2.21	1.11	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	108.52	15.91	16.61	2.47	6.01	1.77	2.12	3.18	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	83.34	9.22	11.43	3.32	3.69	1.84	0.74	2.21	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	69.08	17.27	6.91	1.15	2.30	0.00	4.61	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	107.45	18.80	13.43	1.54	4.61	0.00	1.92	0.38	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	88.32	10.76	9.62	3.96	3.40	1.70	1.13	0.57	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	77.12	15.59	11.49	1.64	1.64	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	116.13	14.01	18.53	4.52	4.97	1.81	4.07	1.36	4.07
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	95.51	11.49	9.34	2.87	1.44	0.72	2.87	1.44	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	94.11	21.66	12.70	5.23	1.49	1.49	1.49	0.75	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	119.28	18.95	15.24	4.46	4.46	1.11	2.60	2.60	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	85.29	9.91	10.34	3.02	3.02	0.43	0.86	2.58	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	98.47	12.84	11.99	1.71	0.86	0.86	3.43	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	111.95	14.99	14.33	4.00	3.66	1.33	2.00	2.33	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	123.68	17.50	11.46	4.83	1.81	0.60	0.00	1.81	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	93.85	22.75	17.06	2.84	2.84	0.71	1.42	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	105.18	19.59	13.06	4.81	3.78	2.06	3.09	1.03	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	102.52	17.71	9.66	3.22	0.54	2.68	1.61	1.61	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	92.25	14.14	6.73	4.04	2.69	1.35	1.35	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	121.86	16.30	14.08	4.44	3.70	1.11	1.48	2.22	4.07
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	60.47	16.28	9.30	9.30	2.33	1.16	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	80.39	13.75	7.40	1.06	2.12	1.06	4.23	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	116.84	16.41	14.01	4.00	2.80	0.40	1.20	1.20	4.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	101.04	9.45	9.45	4.36	6.54	0.73	0.00	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	86.62	16.10	19.93	5.37	3.07	0.77	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	95.20	17.26	17.76	5.43	2.96	1.97	0.49	1.97	5.43
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	90.33	13.17	5.65	2.82	0.94	0.00	0.00	0.94	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	93.52	13.07	12.57	4.53	4.53	4.02	0.00	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	97.33	13.52	15.32	2.25	4.96	1.35	0.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	103.27	5.16	1.72	1.72	5.16	1.72	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	94.41	16.92	10.24	3.56	3.56	0.89	1.34	1.34	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	123.56	17.60	14.86	2.35	2.74	1.96	0.78	3.13	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	75.21	7.92	7.26	5.28	0.66	0.66	1.32	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	97.04	11.94	11.42	4.67	2.08	1.04	1.56	2.59	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	106.33	23.19	14.00	3.50	4.38	1.31	1.31	2.19	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	73.24	11.18	5.59	4.47	3.91	1.68	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	95.84	11.48	13.25	3.97	2.21	0.44	1.77	3.09	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	94.50	16.20	8.87	3.09	3.09	1.93	1.93	2.70	3.86
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	73.42	15.19	8.61	2.03	2.03	0.51	3.54	2.03	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	82.19	15.86	13.94	2.88	1.44	0.96	1.44	1.44	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	101.77	14.31	12.32	4.37	3.18	0.80	1.99	0.80	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	63.19	7.29	6.08	0.61	1.82	1.82	1.22	0.00	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.27	13.14	2.77	0.69	0.00	0.00	1.38	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	102.98	15.96	9.88	3.80	4.18	0.00	0.76	1.14	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	79.01	14.46	9.81	2.07	3.61	1.55	2.58	0.52	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	53.81	17.53	10.88	1.81	0.00	0.60	3.02	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	90.00	14.89	12.99	4.12	3.17	0.95	3.49	1.90	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	78.90	13.33	10.66	3.73	3.73	2.13	4.26	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	59.77	15.52	9.19	2.30	2.30	0.00	3.45	1.15	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	91.53	18.00	12.86	4.11	4.11	1.54	2.57	1.54	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	84.88	14.85	12.73	2.83	0.71	2.83	3.54	2.83	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	65.26	12.48	9.65	2.84	1.13	0.00	4.54	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	83.20	14.98	12.48	5.41	6.24	1.25	0.00	2.50	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	86.13	15.66	8.61	3.13	3.92	2.35	3.92	0.00	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	59.71	10.02	11.69	2.92	0.84	1.25	2.51	1.25	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	94.32	24.63	11.15	4.18	2.79	0.93	3.25	0.93	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	82.29	16.73	15.39	2.01	3.35	1.34	0.67	2.01	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	67.90	13.90	11.23	3.74	1.07	1.60	2.14	1.07	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	99.41	16.16	16.97	6.06	4.04	2.42	0.40	2.02	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	80.76	11.01	16.52	3.67	2.75	0.92	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	58.68	12.45	7.11	4.45	1.78	0.89	2.67	1.78	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	115.68	19.38	13.11	1.71	2.85	2.28	2.28	4.56	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	97.40	16.10	10.74	5.37	0.00	0.77	0.77	4.60	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	55.81	12.04	4.92	2.74	3.28	0.55	1.64	0.55	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	98.44	24.50	13.36	6.24	1.34	0.00	4.01	1.34	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	106.06	17.94	18.72	3.64	2.60	0.78	1.30	2.34	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	53.05	9.95	10.61	3.32	0.66	2.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	91.46	8.31	14.55	4.16	2.08	0.00	2.08	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	144.95	13.67	10.03	1.82	1.37	0.68	0.23	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	167.18	26.79	22.94	8.99	2.75	0.37	0.73	2.02	0.55
Macrophage - monocyte derived, donor3	11389-118C3	164.38	25.30	20.06	6.55	2.75	0.39	0.66	2.10	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	11.15	9.56	7.97	1.59	1.59	0.53	4.25	0.00
Mallassez-derived cells, donor2	11929-125I3	39.77	18.38	19.33	13.79	1.74	1.90	1.11	6.34	0.00
Mallassez-derived cells, donor3	11930-125I4	40.31	20.43	15.71	11.26	0.69	0.97	0.83	3.61	0.42
Mammary Epithelial Cell, donor1	11273-116H4	14.85	10.96	9.17	3.99	0.40	0.90	1.89	1.00	0.30
Mammary Epithelial Cell, donor2	11350-117G9	15.06	13.90	10.13	6.08	0.29	0.58	1.74	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	28.19	19.21	12.97	4.74	0.75	1.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	99.66	4.07	2.03	0.00	1.36	0.00	3.39	0.00	0.00
Mast cell, donor1	11563-120D6	234.02	15.36	7.14	2.05	3.68	0.87	0.54	0.32	1.30
Mast cell, donor2	11565-120D8	208.32	22.88	12.78	1.19	9.21	1.19	8.92	0.89	0.30
Mast cell, donor3	11566-120D9	265.20	24.99	9.91	3.15	15.31	1.58	4.50	1.58	1.58
Mast cell, donor4	11567-120E1	261.68	19.15	9.93	2.84	11.88	1.77	5.67	0.89	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	208.81	13.97	5.32	1.22	4.55	0.33	0.55	1.00	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	87.55	7.00	4.09	2.33	5.25	0.58	1.75	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	158.55	10.10	5.51	1.15	5.39	0.34	0.23	0.23	1.26
Mast cell, expanded, donor8	11941-126A6	135.57	11.38	4.02	1.17	9.21	1.00	0.17	0.00	0.50
Melanocyte - dark, donor1	11502-119F8	108.35	13.13	4.18	1.89	0.99	0.50	0.20	0.80	0.30
Melanocyte - dark, donor2	11582-120F7	56.41	13.50	11.42	2.08	0.35	1.73	0.35	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	30.21	11.59	6.74	2.03	0.29	0.29	0.29	0.29	0.51
Melanocyte - light, donor1	11274-116H5	40.43	19.98	11.52	2.82	1.65	0.71	0.24	0.71	0.71
Melanocyte - light, donor2	11351-117H1	47.09	23.89	9.55	6.82	1.36	0.68	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	34.69	17.34	11.27	3.47	1.73	0.00	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	30.40	12.81	5.41	1.35	0.31	0.10	0.52	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	27.43	21.25	14.52	4.30	0.27	0.81	0.81	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	71.25	20.36	13.12	3.21	0.54	1.87	1.34	0.27	0.54
Meningeal Cells, donor1	11493-119E8	47.14	18.11	9.68	3.72	0.99	0.50	0.50	0.87	0.37
Meningeal Cells, donor2	11573-120E7	60.30	14.97	4.84	2.20	0.88	0.00	0.44	1.32	0.44
Meningeal Cells, donor3	11654-122E7	25.59	10.43	7.82	2.77	0.16	0.33	0.16	0.33	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	28.23	12.55	7.13	3.14	0.29	1.43	0.00	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.78	11.37	10.16	4.13	1.01	1.21	0.50	1.91	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	161.64	39.42	31.54	2.63	3.94	1.31	1.31	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	6.54	13.08	2.62	2.62	0.00	1.31	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	34.45	17.94	9.33	2.15	0.72	0.00	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	49.34	12.92	11.86	6.56	1.27	1.48	0.21	1.06	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	20.61	12.06	9.55	4.52	1.51	2.51	0.50	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.44	13.19	6.81	3.08	0.00	0.44	0.00	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	13.15	7.31	2.92	0.73	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.69	10.43	10.23	2.86	1.02	0.82	0.00	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.06	14.13	8.59	4.02	0.14	1.11	0.14	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	95.90	22.30	12.27	6.69	2.23	0.00	0.74	1.86	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	90.79	13.95	9.21	3.29	1.32	1.84	0.00	1.32	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	36.50	15.73	5.04	1.78	0.30	0.59	0.00	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	42.04	11.68	7.01	2.34	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	9.61	14.73	10.25	3.20	1.28	0.64	0.00	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.42	16.30	10.28	8.51	0.00	0.00	0.71	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	84.44	10.95	9.69	3.44	0.94	1.25	0.63	1.88	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	6.53	7.98	2.18	0.00	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	80.08	32.09	24.66	16.71	6.10	5.83	0.00	10.87	2.92
Mesothelial Cells, donor2	12156-128G5	27.53	13.51	12.51	7.51	0.50	2.50	0.00	4.00	0.00
Mesothelial Cells, donor3	11402-118D7	39.10	24.06	21.53	9.83	2.46	4.34	1.16	4.48	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	144.48	9.45	9.45	4.05	1.35	4.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	123.63	16.50	17.24	6.65	2.22	1.48	0.74	1.97	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	160.48	20.91	28.27	8.24	4.12	1.77	0.59	1.77	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	93.34	20.74	13.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	92.05	10.85	9.30	3.10	1.24	0.31	0.31	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	118.24	20.33	18.88	6.64	1.87	1.04	1.04	2.49	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	74.11	11.58	4.63	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	98.60	17.27	14.01	7.01	2.25	1.25	1.75	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	155.94	25.60	23.27	11.17	1.40	1.86	0.93	4.19	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	19.47	19.47	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	84.33	15.44	10.77	5.28	1.22	0.61	1.42	1.42	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	145.71	20.19	19.40	5.94	3.56	0.00	0.40	3.96	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	84.95	20.35	7.96	5.31	0.88	1.77	0.00	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	129.94	17.86	16.72	6.46	1.14	2.28	1.52	2.28	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	86.85	11.84	9.21	5.26	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	111.42	11.04	11.04	3.18	3.18	0.64	1.70	1.27	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	122.47	15.65	12.89	3.68	0.00	1.84	0.00	5.52	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	84.65	12.52	7.75	2.68	0.60	0.60	0.60	1.79	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	130.78	16.77	13.41	3.35	0.00	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	87.82	10.79	9.79	2.26	2.26	1.25	1.00	0.00	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	123.35	19.01	18.78	6.42	2.38	0.95	0.48	3.80	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	70.22	6.63	4.98	5.53	1.11	1.66	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	107.99	10.82	9.44	2.53	2.07	1.38	1.15	0.46	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	132.30	18.30	21.24	5.89	1.26	1.47	1.05	4.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	102.32	13.05	11.01	3.67	3.47	1.02	1.83	0.41	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	89.03	10.08	5.15	2.15	0.86	0.21	0.43	1.29	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	131.82	18.45	17.12	5.33	0.89	0.89	0.67	2.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	10.32	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	99.87	9.42	7.88	2.41	1.75	0.88	0.22	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	161.21	14.19	12.17	5.07	0.00	1.01	0.00	4.06	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	96.11	16.57	6.63	4.97	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	125.30	10.33	8.70	3.81	1.36	1.63	0.82	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	170.86	21.17	17.06	8.82	1.76	1.76	0.88	1.18	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	100.31	7.63	8.72	0.00	2.18	4.36	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	106.20	8.65	7.69	0.96	0.96	0.96	0.48	0.96	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	198.11	17.21	19.61	6.40	4.80	1.60	1.20	2.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	111.07	9.60	6.86	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	125.14	11.01	7.01	3.50	2.50	1.50	0.00	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	26.95	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	101.93	4.08	2.04	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	126.56	5.69	5.26	2.63	1.31	0.00	0.44	1.31	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	172.17	25.38	9.93	5.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	167.14	6.40	6.40	1.92	0.00	1.92	1.28	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	149.99	10.66	5.95	3.47	2.23	0.99	0.25	1.49	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	217.82	22.96	9.74	6.26	1.39	2.78	0.00	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	181.21	11.05	8.84	0.00	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	181.54	9.57	6.84	1.71	3.08	0.68	0.34	0.68	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	161.48	11.82	10.07	3.06	0.88	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	142.39	9.94	3.20	0.71	0.36	0.36	0.71	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	197.51	6.45	3.93	2.52	3.09	0.84	0.56	1.12	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	226.93	14.96	10.39	7.07	1.66	1.25	0.42	1.25	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	185.31	5.83	5.24	2.33	2.33	1.17	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	212.67	7.54	4.52	3.92	3.32	1.21	0.30	0.60	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	254.61	19.20	12.94	5.84	5.01	0.83	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	173.25	0.00	0.00	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	219.81	6.46	0.92	1.85	1.85	2.77	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	236.18	12.52	10.24	2.85	3.98	1.14	0.57	1.14	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	175.63	8.15	2.90	1.38	2.63	0.41	0.83	0.69	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	216.39	4.66	6.48	1.30	3.11	1.30	0.00	0.52	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	227.36	15.44	9.44	3.00	0.00	0.86	0.00	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	186.75	8.26	3.81	0.64	0.00	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	242.60	4.00	2.67	1.07	4.00	0.80	0.80	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	287.95	15.86	13.77	6.88	4.79	0.30	0.90	1.50	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	162.30	6.64	4.52	1.84	3.81	0.57	0.42	1.27	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	218.18	7.64	4.14	3.50	2.55	0.96	0.64	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	316.22	11.06	8.18	3.98	4.20	0.88	0.44	1.33	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	227.90	5.69	5.31	1.90	1.52	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	193.48	5.40	3.13	1.70	3.98	1.42	0.28	0.57	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	319.79	10.32	9.83	1.97	4.42	0.98	0.74	3.20	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	167.48	5.21	5.87	2.61	2.61	0.65	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	263.45	7.64	4.12	2.65	3.53	1.47	0.29	1.47	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	358.97	13.84	10.38	6.63	3.46	1.44	0.29	2.02	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	290.15	13.19	11.13	7.01	3.71	2.06	0.00	0.82	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	288.25	8.34	7.44	1.49	2.38	2.08	1.19	0.60	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	86.64	3.77	0.00	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	42.77	7.13	5.35	1.78	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	159.36	14.46	9.86	3.94	3.29	1.64	0.33	0.33	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	97.83	6.31	7.36	1.05	3.16	2.10	2.10	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	138.97	12.45	7.91	4.55	2.17	0.99	0.20	0.99	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	120.14	9.31	8.38	2.79	0.00	1.86	0.93	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	114.54	8.26	6.01	1.13	1.13	0.38	0.00	1.50	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	116.39	13.85	10.65	1.33	2.13	1.86	1.07	1.60	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	115.93	9.95	7.46	2.83	1.36	0.57	0.23	1.47	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	125.24	9.58	5.16	1.47	0.00	2.21	0.74	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	139.97	9.89	7.69	4.03	1.83	0.37	0.37	0.73	2.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	102.67	17.11	12.44	6.22	6.22	0.00	1.56	1.56	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	90.85	12.29	6.41	3.21	1.07	0.00	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	96.60	11.59	11.59	7.73	3.86	0.00	0.00	0.00	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	161.59	15.15	6.06	2.02	2.02	3.03	1.01	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	90.23	12.65	9.28	1.69	1.26	0.84	0.00	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	95.34	9.53	1.36	4.09	5.45	0.00	4.09	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	101.73	3.81	1.91	0.64	0.64	1.27	1.91	1.27	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	93.13	4.05	1.62	1.62	0.81	0.81	1.62	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	70.99	6.04	3.02	4.53	0.00	6.04	6.04	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	531.05	5.71	17.13	11.42	5.71	17.13	17.13	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	212.06	6.52	9.79	0.00	0.00	9.79	29.36	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	289.90	19.01	0.00	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	175.69	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	35.76	7.76	11.20	5.60	1.08	1.08	0.43	2.15	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	27.70	9.93	9.41	3.66	1.05	1.57	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	8.68	6.01	1.33	0.67	1.33	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	9.18	9.18	1.67	0.00	4.59	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	4.56	10.84	5.51	1.33	0.95	0.95	0.57	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	14.36	6.38	3.19	1.60	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	5.44	5.44	0.68	0.68	2.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	12.86	11.03	0.00	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.95	8.37	6.70	2.51	2.51	1.26	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.21	10.69	10.69	2.56	0.93	3.02	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.67	6.49	5.13	3.51	2.70	1.62	0.00	0.81	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.54	10.72	10.09	2.52	0.84	0.84	0.21	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	33.40	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	21.34	10.92	10.42	2.48	4.47	0.99	0.50	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	30.86	7.04	6.50	1.35	1.62	0.81	1.08	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.76	7.25	7.71	3.17	1.81	1.81	0.00	1.59	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.92	5.88	4.57	1.31	1.14	1.31	0.33	0.49	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	50.30	12.76	9.66	2.19	1.28	1.09	0.55	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.99	8.49	7.96	2.12	1.06	2.12	0.53	1.06	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	30.02	4.80	5.40	0.60	2.40	1.80	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	33.15	6.89	4.27	2.30	0.33	0.98	0.33	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	21.30	10.08	6.83	3.25	1.95	0.81	0.00	0.33	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	48.86	11.11	7.94	1.76	0.53	2.29	0.00	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	25.32	4.22	6.33	0.70	0.00	2.81	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.55	5.52	5.06	0.92	1.38	1.38	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.35	9.64	8.35	2.89	2.89	1.29	0.64	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.45	12.07	7.93	3.79	2.41	1.03	0.34	0.00	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	17.70	17.70	7.59	0.00	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	33.19	10.25	7.57	2.01	0.22	1.11	1.56	0.89	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	4.66	0.85	0.85	1.27	0.85	0.00	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.12	5.93	3.80	0.95	1.19	1.90	0.47	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	28.76	6.01	5.15	1.72	1.72	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	36.11	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.66	4.67	5.33	0.33	1.67	2.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	31.11	6.76	2.71	2.71	1.35	0.90	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.09	5.16	4.36	0.79	0.79	0.40	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	3.71	5.57	1.86	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.46	5.30	3.78	0.76	1.51	0.76	0.38	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	30.31	8.15	9.12	1.96	1.30	0.33	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	6.97	2.18	0.00	0.00	1.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	24.88	12.21	5.43	0.90	0.90	1.36	0.90	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	1.76	1.76	0.00	1.76	2.65	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	5.98	5.32	1.99	0.66	0.00	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	31.75	5.95	3.47	1.98	1.49	1.49	0.50	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	26.41	6.89	4.21	3.06	0.00	1.53	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.05	9.98	6.96	1.21	1.51	1.21	0.30	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.85	8.62	7.96	1.33	1.11	1.33	0.88	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	6.78	4.74	2.03	1.36	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	15.33	5.11	0.00	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	19.51	7.93	7.32	1.22	0.61	1.22	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.53	8.81	5.04	2.20	1.26	1.26	0.00	0.63	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.44	4.24	2.72	0.61	0.61	0.91	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	10.28	4.75	1.58	1.58	2.37	0.79	0.00	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	13.60	2.27	1.13	2.27	2.27	2.27	1.13	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	10.12	10.12	0.00	0.00	0.00	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	10.68	11.68	10.06	2.61	0.75	1.86	0.37	1.24	0.00
Myoblast, donor2	11322-117D8	24.36	11.70	14.00	4.41	0.77	1.73	2.11	0.96	0.38
Myoblast, donor3	11398-118D3	7.23	13.28	9.75	3.70	0.50	1.68	0.34	1.18	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	151.19	12.99	6.28	0.88	1.17	0.44	0.00	0.29	1.17
Natural Killer Cells, donor1	11230-116C6	418.84	7.38	7.69	0.92	8.92	2.77	0.92	0.92	1.85
Natural Killer Cells, donor2	11311-117C6	428.21	11.16	6.03	2.41	9.05	1.21	0.90	1.81	3.32
Natural Killer Cells, donor3	11387-118C1	352.28	10.49	7.73	2.21	9.20	1.66	0.55	0.92	1.47
Neural stem cells, donor1	11275-116H6	48.63	18.51	14.15	5.08	0.73	2.18	0.36	2.18	1.81
Neural stem cells, donor2	11352-117H2	50.07	19.26	7.70	0.00	3.85	3.85	0.00	1.93	0.00
Neurons, donor1	11494-119E9	22.76	1.14	3.41	1.14	0.00	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	14.53	4.40	2.20	0.22	0.22	0.22	0.22	0.00	0.00
Neurons, donor3	11655-122E8	9.04	2.47	1.64	0.00	0.82	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	398.11	0.00	0.93	1.86	7.42	1.86	0.93	0.00	30.62
Neutrophils, donor2	11314-117C9	472.52	2.90	0.00	0.00	5.80	0.00	0.00	5.80	31.89
Neutrophils, donor3	11390-118C4	576.02	4.28	1.83	1.22	8.55	5.50	0.61	0.61	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	91.90	16.15	14.13	2.61	1.31	0.24	0.12	1.42	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	62.84	16.61	16.28	1.30	0.65	0.00	0.00	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	28.28	13.24	7.22	2.21	0.40	0.20	0.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	33.59	8.12	6.61	1.65	1.10	0.83	0.83	0.69	1.10
Olfactory epithelial cells, donor2	11934-125I8	21.86	13.90	10.86	2.89	0.58	2.46	1.16	0.29	0.72
Olfactory epithelial cells, donor3	11935-125I9	29.74	12.26	7.15	2.38	1.02	1.70	0.57	1.02	0.11
Olfactory epithelial cells, donor4	11936-126A1	43.54	11.79	9.25	1.95	0.97	0.88	0.49	0.39	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	74.02	31.90	10.83	7.22	0.60	1.81	0.60	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	31.90	9.36	7.87	3.40	1.28	0.64	0.43	1.49	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	6.86	3.43	2.29	1.14	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	23.59	5.59	1.86	0.62	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	14.66	7.23	8.01	2.93	0.59	0.39	0.20	0.59	0.20
Osteoblast, donor2	11354-117H4	6.32	12.64	9.13	4.21	0.00	0.70	0.00	2.11	0.00
Osteoblast, donor3	11426-118G4	18.48	11.37	11.55	3.02	0.71	1.24	0.71	1.60	0.00
Pancreatic stromal cells, donor1	11249-116E7	39.25	11.54	15.16	3.71	1.18	3.12	0.42	1.77	0.59
Pericytes, donor1	11491-119E6	28.71	19.69	11.79	8.90	1.34	0.33	0.78	1.22	0.22
Pericytes, donor2	11571-120E5	39.61	12.68	4.98	4.07	1.13	0.68	0.23	1.36	0.00
Pericytes, donor3	11652-122E5	43.95	15.67	10.99	4.27	1.02	1.42	0.61	1.63	1.02
Perineurial Cells, donor1	11499-119F5	58.09	13.11	8.82	2.60	0.34	0.45	0.23	1.24	0.34
Perineurial Cells, donor2	11579-120F4	64.50	16.38	13.89	2.85	0.83	0.55	0.55	1.47	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	267.74	5.74	3.82	2.23	3.82	0.96	0.64	0.64	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	239.23	4.16	2.69	0.73	6.61	1.71	1.22	0.24	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	325.61	8.80	5.69	1.16	4.40	0.78	0.65	0.00	0.91
Placental Epithelial Cells, donor1	11278-116H9	9.57	9.57	7.65	1.91	0.00	0.24	0.96	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	19.96	13.31	11.09	3.33	0.00	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	20.81	15.90	11.19	2.94	0.20	0.39	0.39	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	14.87	11.71	6.33	1.58	1.58	1.27	0.00	0.32	0.95
Preadipocyte - breast, donor1	11467-119B9	19.51	9.00	4.69	1.69	0.56	1.69	0.38	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.66	10.05	6.00	0.91	0.26	1.17	0.00	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	20.26	11.71	6.53	2.03	0.68	1.13	0.23	0.68	0.68
Preadipocyte - omental, donor1	11468-119C1	19.18	6.61	5.11	1.49	2.45	1.70	0.32	0.32	0.75
Preadipocyte - omental, donor2	11329-117E6	25.32	13.09	10.91	1.31	1.31	0.87	0.00	0.87	1.31
Preadipocyte - omental, donor3	11403-118D8	23.92	14.75	8.45	1.72	1.43	2.29	0.43	0.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	8.86	16.73	4.92	1.97	1.97	0.98	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.82	8.29	12.90	6.14	1.54	2.15	1.84	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	37.89	17.88	9.21	4.43	0.71	1.06	0.89	1.24	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	29.46	12.43	14.47	4.77	0.85	2.04	1.02	2.21	1.36
Preadipocyte - visceral, donor1	11280-116I2	28.41	16.67	16.39	4.75	0.93	1.58	0.19	1.40	0.84
Preadipocyte - visceral, donor2	11357-117H7	29.91	24.39	14.73	6.90	2.30	7.82	0.92	2.76	1.84
Preadipocyte - visceral, donor3	11429-118G7	17.45	12.64	11.28	4.81	0.84	2.72	0.21	1.04	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	34.24	4.53	3.77	0.60	2.11	0.30	0.60	0.45	0.30
Prostate Epithelial Cells, donor2	11331-117E8	49.16	21.94	21.26	10.70	4.06	2.98	0.27	5.42	3.11
Prostate Epithelial Cells, donor3	11404-118D9	7.35	5.76	5.21	2.51	0.61	0.61	0.61	0.49	0.49
Prostate Stromal Cells, donor1	11254-116F3	33.03	9.91	8.20	1.71	1.25	0.57	0.46	0.80	0.11
Prostate Stromal Cells, donor2	11332-117E9	73.87	10.22	11.12	4.30	1.61	1.61	0.36	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	90.51	13.97	8.45	3.65	3.02	1.88	0.63	1.36	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	152.93	21.53	16.06	3.28	0.73	0.36	0.73	1.82	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	85.18	15.32	11.71	4.92	0.69	0.49	0.76	2.29	0.35
Renal Epithelial Cells, donor1	11517-119H5	150.14	33.98	20.29	6.59	2.54	0.00	0.00	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	108.12	10.67	9.25	7.82	4.98	1.42	0.00	2.13	1.42
Renal Epithelial Cells, donor3	11678-122H4	159.96	23.40	16.94	4.23	1.91	0.32	0.21	2.12	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	58.55	21.11	8.17	5.45	4.09	0.68	0.00	1.36	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	33.96	16.98	8.36	2.02	1.48	0.81	0.67	0.94	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	39.30	16.43	6.44	2.00	1.11	0.44	0.89	0.67	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	151.72	16.64	17.30	3.33	5.32	0.67	0.67	1.33	2.66
Renal Mesangial Cells, donor1	11518-119H6	48.42	21.79	13.65	8.36	0.66	1.54	0.66	1.54	0.66
Renal Mesangial Cells, donor2	11598-120H5	73.98	17.56	12.54	5.64	0.63	0.63	0.63	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	86.83	22.19	13.87	6.38	1.39	0.83	1.11	1.39	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	109.25	22.28	11.81	4.56	2.68	0.00	0.81	2.15	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	66.21	16.45	8.86	5.90	1.69	1.27	0.42	1.27	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	70.39	19.48	8.29	1.54	1.16	0.58	0.00	1.16	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.60	19.19	8.56	2.07	0.78	0.78	0.00	1.56	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	58.27	17.34	5.97	1.99	0.85	0.28	0.28	1.71	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	17.50	16.47	5.15	2.06	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.31	4.01	1.51	1.00	0.00	0.25	0.50	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	167.58	10.42	6.41	1.60	2.81	0.80	0.94	0.53	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	8.04	0.89	0.89	0.00	1.79	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	40.73	11.56	4.40	0.55	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	28.42	11.60	6.38	1.74	1.16	0.00	0.58	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	18.59	13.13	5.33	0.65	0.78	0.26	0.00	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.43	15.89	6.45	1.19	0.10	0.79	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.12	16.62	7.81	1.78	0.67	0.67	0.11	0.45	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	22.95	20.22	6.20	0.99	0.50	0.37	0.00	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	26.46	16.08	5.83	1.28	1.05	0.35	0.12	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.44	18.49	6.24	1.62	1.62	1.16	0.23	0.46	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	15.47	14.38	5.20	0.82	0.68	0.41	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	24.96	15.28	7.41	1.36	0.61	0.30	0.00	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	27.06	15.95	7.35	0.72	0.18	0.54	0.00	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.38	13.63	4.30	0.72	0.29	0.14	0.00	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	28.12	15.56	6.22	1.29	0.86	0.86	0.00	0.32	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	28.54	17.70	5.75	1.11	0.44	0.00	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.06	13.00	3.25	0.76	0.19	0.00	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.71	13.97	5.78	0.93	0.28	0.56	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	31.57	13.53	9.21	1.50	0.19	0.75	0.00	0.00	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	18.84	14.86	4.91	1.33	0.27	0.40	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	29.59	15.67	6.23	1.46	0.78	0.58	0.00	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.07	16.04	6.87	1.34	0.38	0.95	0.00	0.19	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.94	16.13	4.81	0.85	0.43	0.75	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	26.07	16.82	6.45	0.84	0.56	0.56	0.00	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.51	16.58	8.89	1.71	0.17	0.68	0.00	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	22.06	13.49	6.20	1.46	0.18	0.00	0.00	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.66	16.43	7.60	0.74	0.37	0.49	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	30.36	19.48	4.97	1.21	1.07	0.54	0.13	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	16.51	13.68	4.72	0.00	0.00	0.24	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.18	18.06	7.14	1.59	0.60	0.20	0.00	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.36	16.37	6.78	1.64	0.94	0.47	0.00	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	18.04	13.27	4.15	1.04	0.00	0.21	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	32.30	17.92	4.42	1.77	1.33	0.66	0.22	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.07	16.50	8.15	0.63	1.25	0.63	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.78	13.59	7.13	1.21	0.40	0.27	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	25.88	14.65	4.94	1.02	1.02	0.34	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	33.35	14.07	7.52	0.96	0.58	0.77	0.00	0.19	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.98	15.47	8.25	0.69	0.52	0.34	0.00	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.47	17.56	6.72	1.92	1.10	0.69	0.14	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	28.73	16.58	5.25	0.82	1.48	0.49	0.00	0.16	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.52	17.55	5.62	1.19	0.17	0.85	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.88	19.83	9.17	2.07	1.63	0.59	0.00	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	35.45	18.13	8.80	1.87	0.53	0.80	0.27	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.63	16.45	4.29	1.11	0.41	0.28	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.38	21.43	6.67	1.19	0.95	0.24	0.24	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.92	20.76	10.88	1.01	2.02	1.01	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.24	17.99	4.61	1.32	0.94	0.38	0.09	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	48.21	21.66	6.29	0.70	0.35	1.40	0.00	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	37.17	16.32	5.14	0.91	1.81	1.51	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.37	19.09	5.87	0.86	0.73	0.49	0.12	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	81.36	22.85	11.06	2.77	0.44	0.58	0.29	0.29	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	53.54	21.90	15.82	0.00	1.22	0.61	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	39.48	15.97	5.73	0.30	0.30	0.30	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	106.99	33.25	14.02	1.81	3.17	0.45	0.23	0.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	84.77	27.56	11.38	1.80	1.80	0.30	0.30	0.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	70.49	25.39	7.20	1.30	2.60	0.12	0.00	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	103.95	31.16	10.03	2.35	6.62	0.43	0.21	0.85	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	61.90	25.84	13.22	1.80	2.40	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	64.32	19.18	7.90	3.01	1.13	0.75	0.19	0.94	0.00
Schwann Cells, donor2	11578-120F3	34.02	0.00	6.80	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	42.28	12.05	8.33	1.10	0.66	0.66	0.22	0.44	0.66
Sebocyte, donor1	11220-116B5	71.21	35.61	30.68	16.98	2.19	1.10	0.00	9.31	0.00
Sebocyte, donor2	11301-117B5	34.93	18.84	17.00	6.89	2.30	1.38	1.38	4.60	1.38
Sebocyte, donor3	11378-118B1	60.80	17.52	17.93	8.86	2.68	1.86	0.21	3.09	1.03
Sertoli Cells, donor1	11255-116F4	33.13	19.88	21.54	6.63	6.63	1.66	3.31	3.31	0.00
Sertoli Cells, donor2	11333-117F1	53.66	11.30	5.65	0.00	0.00	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	30.53	8.80	6.07	1.32	0.62	0.18	1.23	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	18.79	5.06	4.34	0.00	0.72	0.00	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	12.54	10.03	0.00	0.84	2.51	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	13.51	10.53	4.71	2.04	0.63	0.00	0.47	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	16.95	10.70	4.91	2.38	1.04	0.30	0.45	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	20.16	9.23	6.46	2.15	0.62	0.15	0.46	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	42.59	11.21	7.31	3.65	1.13	0.50	0.38	1.39	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.41	8.42	7.13	2.43	0.71	1.57	0.86	1.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	29.96	12.30	9.13	2.28	0.79	0.30	0.50	0.50	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.75	7.58	4.63	1.94	0.34	0.51	0.51	0.25	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	14.48	10.86	3.62	0.72	0.00	1.45	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.97	12.38	7.43	4.13	0.96	0.55	0.83	0.55	0.14
Skin - palm, donor1	10286-104F7	29.55	5.37	5.37	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.15	9.95	9.23	6.34	2.59	0.86	0.72	2.16	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	6.54	1.64	4.91	0.00	4.09	7.36	0.82	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.44	10.39	10.26	4.93	3.38	1.17	0.26	2.34	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	29.75	13.21	16.96	9.31	1.25	1.39	1.95	4.31	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	34.18	16.03	16.88	7.31	2.95	2.95	3.94	1.69	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	43.13	22.62	23.68	10.78	0.85	3.81	9.52	5.50	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	35.90	15.59	16.26	6.97	1.20	1.65	3.30	2.62	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	2.16	5.25	2.47	0.93	0.93	2.16	0.31	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	30.90	26.01	16.01	9.78	0.89	3.11	0.67	2.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.81	21.75	14.70	8.23	1.18	4.70	0.59	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	73.59	15.25	13.26	7.07	1.10	1.99	0.88	1.99	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	21.66	14.18	11.03	9.45	0.79	3.94	0.39	2.36	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	22.40	19.31	25.49	9.27	1.55	3.86	1.55	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	75.06	6.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.90	20.23	14.90	8.92	1.33	2.13	0.80	2.26	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.40	8.64	9.75	1.99	0.22	1.77	0.66	0.66	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.68	11.14	5.63	3.20	0.38	0.64	0.51	0.51	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	43.95	12.37	6.19	4.88	1.30	0.33	0.65	1.30	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.30	13.58	9.45	5.61	1.77	1.48	0.00	1.77	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.74	18.51	15.80	8.68	1.57	1.28	0.71	1.99	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	42.30	22.45	11.88	6.02	0.65	1.46	0.33	1.95	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.75	5.18	3.04	0.30	0.61	1.22	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	34.60	18.44	14.65	6.82	1.52	1.77	1.26	1.01	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	6.12	18.36	18.36	0.00	6.12	12.24	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.56	15.26	12.40	3.34	0.95	2.38	1.43	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.99	10.91	7.67	3.98	1.18	1.03	0.15	1.18	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	21.95	9.69	8.82	2.58	1.29	1.94	0.22	1.29	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	23.51	11.86	8.92	3.46	0.10	1.78	0.10	1.57	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.16	17.32	14.69	7.89	1.55	3.25	0.15	3.56	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	10.78	12.93	4.31	1.08	4.31	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.36	13.75	8.97	2.39	0.60	1.20	1.20	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	53.94	24.58	15.36	5.46	0.68	0.00	1.37	1.71	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	60.00	12.56	10.76	3.38	0.55	0.55	0.55	0.79	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	32.81	19.63	24.66	8.86	4.33	6.54	0.10	3.32	2.52
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	110.14	18.66	15.47	8.65	0.91	6.83	1.82	5.01	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	19.32	11.47	4.83	1.81	3.62	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.81	12.19	8.48	3.18	0.26	0.79	0.26	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	50.87	14.25	8.92	1.86	0.93	1.46	0.67	0.40	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.06	15.03	9.77	3.26	2.00	1.88	0.75	1.38	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	53.52	5.83	6.60	3.04	1.01	1.78	0.00	0.76	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.20	15.68	13.57	5.13	1.66	0.75	0.60	1.36	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	38.26	12.00	11.25	4.50	2.25	1.50	0.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	25.84	3.88	3.88	1.29	2.58	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.07	28.83	19.07	8.37	0.93	4.65	1.40	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	48.97	29.28	21.21	10.60	1.01	4.04	2.52	2.52	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	37.29	16.92	13.79	7.52	2.19	3.45	2.19	2.19	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	33.33	20.94	19.17	6.78	1.77	1.47	0.29	2.95	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	26.66	10.33	8.58	2.50	0.33	0.83	0.08	0.58	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	51.39	11.68	7.94	3.74	0.00	1.40	0.00	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	22.02	20.72	17.13	6.91	2.16	0.86	0.14	2.73	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	31.36	19.89	9.43	4.84	1.78	1.02	0.00	1.27	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.10	12.60	6.58	2.44	0.56	0.56	0.75	0.75	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	17.33	12.72	9.22	1.54	0.42	0.42	0.28	0.70	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.22	13.24	9.38	4.02	0.17	0.17	0.50	1.93	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	22.86	12.38	6.67	3.33	0.48	1.43	0.48	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.98	17.13	15.17	7.83	1.96	1.71	0.24	3.18	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	40.21	13.26	10.38	5.74	2.87	1.99	0.22	1.55	2.21
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.77	10.53	9.66	3.51	0.00	1.76	0.00	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.82	5.44	2.72	0.00	1.17	0.78	0.39	0.19	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.52	3.97	5.82	1.85	0.79	4.50	0.00	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.97	5.21	2.98	3.35	2.23	2.23	0.37	0.00	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.17	14.01	6.47	3.23	1.08	3.95	0.00	1.80	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.38	10.22	8.80	4.54	0.85	7.67	0.57	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.70	8.27	5.91	0.79	0.00	3.15	0.00	0.00	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	14.98	7.11	4.32	2.03	1.02	1.78	0.76	0.25	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	24.36	7.99	3.99	0.40	1.20	0.80	0.00	0.00	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	6.27	3.76	0.84	0.84	1.25	0.84	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	6.42	3.67	2.75	0.92	1.83	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	24.07	9.76	7.91	1.85	1.18	1.01	1.18	0.34	1.18
Synoviocyte, donor2	11368-117I9	64.20	10.56	9.72	3.52	1.01	1.34	1.68	0.50	2.18
Synoviocyte, donor3	11440-118H9	77.97	11.84	8.71	2.68	1.56	0.67	1.34	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	29.66	21.80	9.65	3.22	0.36	2.50	0.00	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	17.84	9.91	1.98	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	39.36	16.21	13.20	3.24	1.39	1.16	0.69	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	28.32	15.84	13.48	5.38	0.93	0.86	0.72	2.58	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	18.56	10.05	7.34	4.25	0.77	0.39	0.39	1.55	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	11.45	12.03	11.45	3.44	1.15	1.15	1.72	2.86	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	183.43	10.33	5.29	1.72	4.92	0.49	1.11	0.00	0.12
Urethra, donor2	10319-105A4	80.93	3.60	1.80	0.00	1.80	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	54.73	23.91	20.46	16.74	0.80	1.59	0.80	7.17	0.27
Urothelial Cells, donor2	11600-120H7	70.90	22.83	20.03	6.41	2.80	0.00	0.00	4.01	1.60
Urothelial Cells, donor3	11681-122H7	66.47	24.30	24.30	7.79	2.75	1.38	1.15	2.98	0.00
Urothelial cells, donor0	11216-116B1	81.58	27.19	27.86	12.48	1.11	1.11	0.89	4.90	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	332.78	12.46	1.78	1.78	1.78	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	335.96	10.01	4.29	1.43	0.00	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	307.35	6.85	2.74	1.37	3.42	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	222.10	6.20	5.51	1.38	1.72	0.69	0.34	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	205.10	2.91	1.16	1.74	1.74	0.58	0.00	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	303.00	7.29	1.04	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	269.83	5.51	4.59	0.00	1.84	0.00	0.92	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	330.47	8.22	3.65	0.91	3.65	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	11.60	13.45	8.14	2.10	0.99	0.37	0.37	1.48	0.25
Wilms' tumor cell line:HFWT	10597-108E3	0.88	2.64	0.88	1.76	0.00	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	67.32	23.74	16.20	4.19	1.68	2.51	0.00	3.35	1.12
achilles tendon, donor2	10292-104G4	53.73	2.07	4.13	2.07	2.07	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	125.18	2.80	1.53	0.51	2.55	0.25	0.00	0.25	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	89.62	10.45	1.86	0.00	0.93	0.00	0.00	0.00	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	103.75	10.80	2.02	0.12	0.59	0.24	0.00	0.00	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	39.18	5.99	2.99	0.27	1.36	0.00	0.27	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	88.26	20.24	6.46	0.56	2.81	0.28	0.00	0.56	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	104.89	10.36	6.56	0.63	0.63	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	93.64	9.26	5.44	0.00	2.18	0.82	0.00	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	45.39	15.42	4.41	2.64	0.44	0.00	0.00	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	219.29	17.56	6.13	0.82	4.08	0.00	0.00	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	154.54	12.43	3.88	0.39	1.55	0.39	0.00	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.95	11.96	4.60	0.37	0.37	0.00	0.00	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	0.00	3.90	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	75.52	12.55	7.20	2.09	2.32	0.70	0.00	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	150.16	13.98	2.59	0.78	2.33	0.26	0.26	0.00	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	135.89	9.94	4.09	0.00	1.46	0.00	0.00	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	93.88	9.76	1.39	0.00	0.46	0.00	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	133.25	12.75	4.94	1.65	4.11	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	72.75	10.44	1.53	0.31	0.31	0.31	0.00	0.31	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	121.61	14.08	4.69	2.13	2.56	0.85	0.00	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	154.68	16.07	9.10	1.52	1.52	0.00	0.00	0.30	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	141.05	16.85	6.02	2.41	1.93	0.24	0.24	0.96	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	28.73	15.81	7.80	1.11	0.89	0.00	0.00	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.01	7.00	4.67	1.00	0.33	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	53.89	16.72	5.57	0.00	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	24.48	11.68	5.27	0.75	0.75	0.00	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	55.39	16.57	5.67	0.44	0.44	0.44	0.44	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	95.60	5.62	1.87	1.87	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	79.13	11.07	9.42	0.24	3.77	1.88	1.18	0.24	0.47
adipose tissue, adult, pool1	10010-101C1	186.45	9.62	5.27	1.86	2.95	0.16	1.40	0.31	1.09
adipose, donor1	10184-103D4	4.10	9.97	2.35	1.17	0.00	0.00	0.59	1.17	0.00
adipose, donor2	10185-103D5	3.65	8.11	2.84	1.62	1.22	0.41	0.41	0.41	0.00
adipose, donor3	10186-103D6	3.81	4.63	1.91	0.27	0.27	0.27	0.00	0.27	0.00
adipose, donor4	10187-103D7	5.20	2.60	0.87	0.87	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.36	42.45	17.68	5.52	0.79	1.42	0.47	2.05	0.63
adrenal gland, adult, pool1	10081-102A9	54.57	3.64	3.64	0.00	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	266.55	4.80	2.00	0.93	4.14	0.40	0.00	0.13	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	39.66	15.01	7.15	2.14	1.07	1.07	1.43	0.71	1.07
amniotic membrane cells, donor1	12235-129G3	51.24	16.00	24.58	4.87	0.70	0.93	1.85	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	47.33	13.52	9.80	1.69	1.69	0.00	0.68	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	12.08	13.85	15.32	3.24	0.88	0.59	2.95	0.59	0.00
amygdala - adult, donor10196	10167-103B5	32.02	18.97	5.93	1.19	0.00	1.19	3.56	0.00	1.19
amygdala, adult, donor10252	10151-102I7	68.33	13.99	6.29	2.43	1.22	1.82	4.87	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	11.62	3.55	2.58	0.32	0.97	2.58	1.61	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	174.95	14.52	5.48	0.89	2.80	0.64	0.38	0.51	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	79.65	10.37	8.60	2.43	1.54	0.00	0.22	0.44	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	13.70	7.68	5.68	0.67	1.34	1.00	0.00	0.00	0.33
aorta, adult, pool1	10052-101G7	57.07	9.61	5.30	0.59	1.18	0.39	2.35	0.00	0.39
appendix, adult	10189-103D9	238.30	8.93	5.43	0.78	7.37	2.72	1.16	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	81.86	15.82	8.25	0.69	4.13	0.69	0.00	0.34	1.03
artery, adult	10190-103E1	21.74	4.08	0.00	0.00	1.36	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	52.59	14.78	5.22	1.16	1.01	0.29	1.01	0.14	0.43
b cell line:RPMI1788	10427-106D4	244.76	3.12	0.59	0.59	1.64	0.74	0.15	0.15	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.31	12.21	8.32	4.99	1.94	2.50	0.55	0.28	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	73.33	10.52	6.25	2.68	0.99	1.19	0.89	1.79	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	20.25	3.01	2.01	0.67	0.50	0.17	0.17	0.33	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.21	4.47	1.68	0.00	1.12	1.12	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	114.29	9.89	3.15	0.65	2.06	0.54	1.41	0.22	0.43
blood, adult, pool1	10053-101G8	228.11	6.64	4.43	4.43	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	56.52	10.28	15.41	2.57	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	127.54	10.12	3.37	2.02	0.67	0.00	0.00	0.00	2.02
brain, adult, donor1	10084-102B3	23.58	9.23	8.20	2.05	6.15	3.08	6.15	2.05	0.00
brain, adult, pool1	10012-101C3	63.03	14.70	9.35	3.01	1.78	2.67	1.56	0.67	1.22
brain, fetal, pool1	10085-102B4	16.03	5.34	10.69	2.67	0.00	2.67	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	44.27	8.59	5.95	0.99	1.65	1.98	0.33	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	48.18	5.62	7.86	1.75	0.37	2.12	0.12	1.12	0.25
breast, adult, donor1	10080-102A8	34.72	4.42	1.89	0.00	1.89	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.33	11.18	6.48	1.40	0.38	0.13	0.13	0.13	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	88.75	10.51	9.90	2.47	2.16	1.24	0.62	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	132.15	44.89	13.58	2.07	4.60	0.46	2.07	1.84	5.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	34.62	12.59	8.72	3.39	0.24	0.97	0.73	0.73	0.24
carcinoid cell line:NCI-H1770	10703-109H1	3.29	2.35	0.94	0.00	0.47	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	42.11	7.88	3.39	0.98	0.66	0.22	0.33	0.33	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	4.12	9.51	2.54	0.00	0.00	0.00	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.90	14.37	4.26	0.00	1.33	0.27	1.60	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	20.72	17.27	6.91	2.30	0.00	2.30	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	63.75	20.41	10.88	2.01	1.51	1.84	2.51	0.84	0.50
caudate nucleus, adult, donor10258	10379-105H1	21.40	19.87	6.88	0.76	0.00	0.76	3.06	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	13.18	8.79	6.23	0.00	0.37	2.20	2.56	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	26.22	17.48	5.83	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	70.89	15.37	11.10	2.56	2.14	1.92	0.85	0.64	0.64
cerebellum, adult, pool1	10083-102B2	27.94	11.04	5.52	2.76	0.34	3.10	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	37.36	8.30	3.32	0.00	0.00	0.83	0.83	2.49	0.83
cerebral meninges, adult	10188-103D8	35.05	12.61	4.79	2.77	1.76	3.28	2.52	0.25	0.76
cerebrospinal fluid, donor2	10294-104G6	24.85	5.12	2.19	0.00	0.73	0.00	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	50.32	39.68	22.43	4.46	1.01	0.43	0.86	0.43	0.86
cervical cancer cell line:ME-180	10553-107I4	57.84	10.61	7.62	2.15	0.33	0.50	0.33	1.16	0.00
cervix, adult, pool1	10013-101C4	115.38	9.87	6.61	0.94	2.20	0.42	3.46	0.31	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	72.04	7.11	5.02	2.51	0.70	1.95	4.32	2.37	1.53
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	3.92	1.31	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	132.35	12.68	4.47	0.12	3.48	0.00	0.50	0.25	2.11
choriocarcinoma cell line:SCH	10785-110H2	51.87	14.42	8.13	2.46	0.49	0.49	1.36	0.62	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	3.79	0.47	0.24	0.00	0.24	0.24	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	122.23	13.68	8.55	1.99	0.85	0.57	1.14	1.42	0.57
chorionic membrane cells, donor2	12239-129G7	93.86	18.99	11.34	2.98	2.59	0.70	2.59	2.49	0.70
chorionic membrane cells, donor3	12240-129G8	98.36	9.89	1.10	1.10	1.65	0.00	1.10	0.55	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	69.68	9.09	4.04	0.00	1.01	0.00	0.00	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	89.90	16.71	4.99	0.38	1.15	0.00	0.00	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	89.33	10.14	5.70	1.06	0.84	0.21	0.00	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.35	13.35	7.45	1.54	1.54	0.00	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	10.88	19.59	13.55	1.45	0.73	0.00	0.24	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	14.05	12.83	9.16	1.83	0.20	0.41	0.00	0.61	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	15.90	14.13	7.95	0.88	0.00	0.00	0.00	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	89.39	13.55	9.12	2.87	1.30	0.52	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	76.12	26.29	13.49	2.74	2.97	0.00	0.23	1.83	3.20
clear cell carcinoma cell line:TEN	10636-108I6	41.29	4.68	3.47	1.21	0.69	0.35	0.00	0.17	0.35
colon carcinoma cell line:CACO-2	10513-107D9	9.88	3.66	2.20	0.55	0.18	0.37	0.18	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	25.09	9.88	4.18	0.76	0.38	1.52	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	108.29	8.33	4.76	1.19	2.38	2.38	4.76	0.00	1.19
colon, adult, pool1	10014-101C5	297.28	13.40	10.11	2.12	13.28	1.65	2.59	0.35	0.82
colon, fetal, donor1	10070-101I7	109.38	8.03	4.94	0.62	3.71	1.85	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	238.34	27.50	0.00	0.00	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	112.61	1.27	0.42	0.00	2.12	1.70	0.00	0.00	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	190.32	3.92	1.36	0.15	2.41	1.21	0.30	0.00	1.66
cord blood derived cell line:COBL-a untreated	10449-106F8	195.86	3.67	2.40	1.13	0.71	0.71	0.14	0.42	1.83
corpus callosum, adult, pool1	10042-101F6	75.40	13.93	8.18	2.32	0.66	2.32	0.77	0.66	0.00
cruciate ligament, donor2	10295-104G7	45.39	3.24	1.62	0.00	0.00	0.00	3.24	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	22.47	7.22	0.00	0.00	0.80	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	30.72	14.16	5.52	1.44	0.96	1.44	0.48	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	134.09	5.97	1.84	0.23	2.53	0.69	0.00	0.00	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	150.27	9.23	3.85	1.80	0.77	0.51	0.77	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	21.42	13.96	18.78	8.43	1.44	3.13	1.93	2.17	0.96
ductus deferens, adult	10196-103E7	106.64	10.47	6.98	1.99	1.99	3.49	1.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	99.38	7.20	1.44	1.44	1.44	0.00	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	144.92	11.03	6.62	0.74	5.15	0.00	2.21	1.47	1.47
dura mater, adult, donor1	10041-101F5	218.94	12.14	9.50	3.22	2.31	0.99	0.83	0.74	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	86.39	3.78	2.00	3.33	3.33	2.44	17.10	3.78	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	3.73	4.01	2.72	0.00	0.29	0.14	0.14	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	66.59	7.40	6.17	0.00	0.62	0.62	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	59.03	15.14	4.24	3.03	1.51	0.61	0.30	2.12	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	57.43	13.89	6.79	1.54	0.62	0.93	0.93	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	85.38	11.82	5.25	0.00	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	129.05	12.07	6.70	2.01	1.34	0.67	2.35	0.67	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	42.23	23.38	7.97	1.81	1.09	1.45	0.72	0.54	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	21.23	8.20	5.47	2.09	0.64	0.96	0.00	0.48	0.48
epidermoid carcinoma cell line:A431	10426-106D3	135.06	12.78	11.34	3.67	1.67	1.78	0.22	1.89	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	107.57	28.16	16.50	7.04	0.99	1.10	0.33	2.20	0.77
epididymis, adult	10197-103E8	141.08	7.95	6.28	1.26	3.77	1.26	1.47	0.21	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	39.03	27.32	29.80	12.06	1.42	1.60	1.06	3.19	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	44.83	5.90	6.29	2.75	1.18	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	41.41	39.18	20.31	4.32	1.31	0.13	0.00	2.62	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	47.34	42.32	21.06	4.63	1.97	0.59	0.30	2.36	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	38.99	38.43	22.85	4.03	1.68	0.56	0.34	2.13	0.34
esophagus, adult, pool1	10015-101C6	126.25	13.17	8.81	2.23	2.97	2.34	0.85	0.64	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	6.26	6.89	3.01	1.75	0.00	0.50	2.00	1.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	28.97	9.66	2.41	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	35.77	2.10	0.00	0.00	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	4.46	0.00	0.00	1.49	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	42.42	5.73	2.29	0.00	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	7.29	2.91	0.00	0.00	1.46	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	64.58	16.02	5.34	1.53	1.53	0.00	0.25	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	43.34	10.64	5.13	1.28	1.15	0.38	0.38	0.64	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	38.70	16.62	9.50	4.51	1.42	0.47	0.47	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	37.62	15.48	10.04	3.57	0.66	2.53	3.57	2.16	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	45.94	10.21	5.40	1.80	0.30	1.20	0.30	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	261.78	41.24	32.83	11.61	2.65	2.47	0.73	6.86	1.19
gall bladder, adult	10198-103E9	132.79	12.80	7.48	1.45	2.90	1.45	2.17	0.72	0.97
gamma delta positive T cells, donor1	11937-126A2	512.70	13.96	11.81	2.15	3.22	0.00	0.00	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	440.72	10.08	5.23	0.37	3.73	0.37	0.00	0.37	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	82.59	5.28	6.55	4.65	4.22	0.84	0.21	1.48	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.76	13.15	6.38	1.93	0.77	0.00	0.77	0.19	1.55
gastric cancer cell line:AZ521	10549-107H9	17.05	28.36	8.03	2.95	0.82	0.98	0.33	1.31	0.49
gastric cancer cell line:GSS	10560-108A2	9.15	5.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	22.62	11.65	4.34	2.28	1.37	0.69	0.00	0.91	0.69
giant cell carcinoma cell line:LU65	10487-107B1	34.19	5.85	3.21	0.69	0.57	0.34	0.92	0.11	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	98.39	20.43	19.03	5.60	1.12	2.66	2.24	1.54	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	44.90	13.47	8.98	0.50	0.50	2.00	0.75	0.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	59.74	13.62	11.82	4.86	1.16	2.01	0.42	0.63	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	59.83	12.50	9.27	2.81	0.42	1.83	0.14	1.69	0.42
glioblastoma cell line:T98G	10485-107A8	90.51	14.57	9.27	2.76	1.55	0.77	0.33	0.99	0.77
glioma cell line:GI-1	10413-106B8	43.35	9.96	4.69	0.88	0.59	1.17	0.00	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	13.85	6.56	5.83	1.46	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	92.76	13.43	5.37	0.98	1.22	0.73	1.71	0.24	0.73
globus pallidus, adult, donor10258	10367-105F7	23.28	8.22	6.85	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	32.51	5.86	3.73	0.53	0.53	2.13	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	332.81	9.79	12.24	0.00	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	196.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	10.45	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	97.28	19.84	8.64	3.52	2.24	1.60	0.64	1.28	0.96
hIPS +CCl2, biol_rep1	14383-156B9	4.59	4.59	1.38	1.38	0.46	0.46	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	5.03	5.03	0.46	0.00	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	2.58	3.86	1.29	1.29	0.00	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	4.31	4.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	1.37	5.49	1.37	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	15.45	5.52	2.21	1.10	0.00	3.31	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	122.41	4.31	2.01	1.15	3.16	0.00	0.00	0.57	1.15
heart - mitral valve, adult	10205-103F7	51.42	10.76	4.19	1.49	0.60	1.49	1.49	0.30	1.20
heart - pulmonic valve, adult	10206-103F8	91.25	11.77	6.28	1.83	0.78	0.00	2.09	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	147.38	7.49	1.67	0.83	3.33	0.00	3.33	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	80.60	18.57	6.33	1.02	2.24	0.82	1.02	0.41	1.84
heart, adult, diseased, donor1	10051-101G6	124.77	15.33	5.11	0.85	1.28	0.43	1.28	0.43	1.28
heart, adult, pool1	10016-101C7	131.78	13.57	5.52	2.07	2.30	0.00	1.15	0.00	0.23
heart, fetal, pool1	10046-101G1	107.51	11.91	6.37	0.92	0.92	0.31	0.62	0.31	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	44.43	17.89	11.42	3.09	0.31	1.54	0.31	0.93	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	53.15	14.36	9.61	2.32	2.98	0.88	0.11	0.77	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	63.84	16.75	12.02	2.43	3.76	0.36	0.00	0.73	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	60.33	17.28	12.63	2.83	2.53	0.30	0.20	0.71	0.51
hepatoma cell line:Li-7	10484-107A7	73.96	10.90	7.23	2.34	0.89	0.67	0.67	0.56	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	154.77	2.81	1.51	0.50	0.70	0.10	0.00	0.20	0.40
hippocampus - adult, donor10196	10169-103B7	25.55	6.62	4.73	2.84	0.95	1.89	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	74.70	15.31	5.71	2.65	1.02	1.63	3.88	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	11.45	12.95	2.49	1.00	0.00	5.48	1.49	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	19.03	12.69	4.23	1.06	1.06	3.17	2.11	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.66	3.66	1.22	0.00	2.44	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.50	2.75	1.18	0.79	0.20	0.20	0.00	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	7.87	4.06	2.54	1.78	0.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.26	3.38	1.13	0.56	1.13	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.91	5.16	1.81	1.03	1.55	0.26	0.00	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2.28	3.80	0.76	0.38	0.76	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	2.04	1.46	0.29	0.00	0.58	0.29	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	2.59	2.80	1.72	0.65	0.22	0.22	0.22	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1.25	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.00	2.60	0.95	0.95	0.00	0.00	0.24	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	7.39	3.38	2.25	0.64	0.80	0.16	0.16	0.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	4.71	2.69	3.37	0.67	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.91	7.51	3.60	0.47	1.41	0.31	0.00	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	22.60	6.39	1.97	1.97	0.98	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.09	4.36	0.00	0.87	1.75	0.00	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.78	8.78	4.20	1.34	0.76	0.00	0.00	0.76	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.54	9.59	1.74	0.87	3.05	0.44	0.44	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	5.50	3.50	3.00	0.00	1.50	0.50	0.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	3.77	7.72	4.71	1.70	1.13	0.00	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	6.37	10.91	3.64	0.91	1.36	0.00	0.00	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1.88	10.34	1.57	0.31	0.63	0.00	0.00	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.86	9.31	5.88	1.31	0.65	0.00	0.49	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.29	6.39	3.77	2.32	1.45	0.00	0.00	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.86	5.98	3.29	2.09	0.90	0.00	0.00	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	6.28	6.10	4.06	0.55	0.92	0.37	0.00	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.99	7.42	2.28	0.29	0.86	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.72	5.31	5.31	0.82	0.41	0.00	0.00	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	4.93	5.28	4.93	2.46	0.35	0.00	0.00	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	2.53	4.75	3.48	0.63	2.53	0.00	0.00	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.93	4.84	1.51	2.42	0.91	0.30	0.30	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4.14	13.45	3.10	0.52	1.55	1.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2.66	10.63	1.33	0.66	2.66	0.00	1.99	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	2.57	4.10	2.31	1.03	0.77	0.26	0.51	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.02	4.35	4.60	1.02	1.28	0.77	0.26	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	5.30	3.03	3.03	0.76	0.00	0.00	0.76	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	6.72	6.39	3.70	2.35	1.68	0.34	0.67	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.28	9.90	4.35	0.48	0.48	0.24	0.00	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	2.67	5.35	2.23	0.45	1.34	0.00	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	3.41	8.29	1.95	1.46	0.49	0.00	0.00	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.14	6.72	2.75	0.61	0.92	0.00	0.00	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	6.51	3.25	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.32	4.30	2.98	0.33	0.66	0.00	0.00	0.33	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1.64	5.47	1.64	1.09	0.55	0.55	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1.45	2.53	1.45	0.72	0.36	0.00	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	2.49	2.85	2.14	1.07	0.36	1.07	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	3.58	1.19	1.19	1.19	0.00	0.00	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	7.85	5.69	3.79	2.84	0.41	0.14	0.27	1.08	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.31	4.58	2.16	1.08	1.62	0.54	0.00	0.54	0.54
immature langerhans cells, donor1	11904-125F5	148.68	3.39	2.66	1.94	2.42	2.91	1.70	0.24	0.00
immature langerhans cells, donor2	11905-125F6	112.48	3.17	3.17	0.79	3.96	4.75	11.09	1.58	0.79
insula, adult, pool1	10039-101F3	43.44	21.77	11.92	3.41	0.47	3.31	5.49	1.70	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	65.68	13.98	8.78	0.65	1.63	0.65	0.33	1.30	0.98
kidney, adult, pool1	10017-101C8	173.72	9.91	4.81	1.30	1.70	0.20	1.70	0.30	0.90
kidney, fetal, pool1	10045-101F9	99.24	9.97	4.17	1.63	0.92	0.42	3.75	0.14	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	145.29	15.48	7.95	0.99	1.28	0.57	2.13	0.85	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	18.11	6.91	2.63	0.97	0.97	0.69	0.28	0.14	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	34.13	12.29	5.87	1.65	0.18	1.10	1.10	0.73	0.37
left atrium, adult, donor1	10079-102A7	53.40	8.17	3.27	1.09	1.09	0.54	1.63	0.54	1.09
left ventricle, adult, donor1	10078-102A6	75.85	7.08	4.05	0.00	1.52	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	9.03	9.58	9.03	3.01	0.27	1.64	0.00	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	21.55	11.14	19.04	11.14	4.31	7.90	1.08	4.67	0.36
leiomyoma cell line:15242A	10570-108B3	22.28	11.41	7.07	3.80	2.72	5.98	0.00	2.17	0.54
leiomyoma cell line:15425	10571-108B4	9.96	15.30	12.14	5.58	3.89	4.13	0.97	2.43	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	53.32	13.59	12.55	3.14	1.05	1.05	2.09	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	61.98	16.06	9.68	1.89	0.71	0.83	0.12	0.35	0.71
liposarcoma cell line:KMLS-1	10782-110G8	31.09	18.28	10.00	3.91	0.62	1.72	0.78	1.56	0.47
liposarcoma cell line:SW 872	10726-110A6	211.15	31.07	20.47	7.43	2.80	0.85	2.19	3.05	0.97
liver, adult, pool1	10018-101C9	232.56	16.04	11.02	1.94	6.97	1.13	0.00	0.97	0.65
liver, fetal, pool1	10086-102B5	18.81	7.53	5.64	0.94	4.70	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	23.48	6.56	3.06	1.17	0.29	1.75	0.29	0.73	0.29
locus coeruleus, adult, donor10252	10165-103B3	55.55	11.81	5.72	0.74	1.48	0.55	0.37	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	35.83	6.77	4.51	1.41	1.13	0.56	0.28	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	34.91	3.79	3.79	2.10	1.26	3.36	1.68	1.26	1.26
lung adenocarcinoma cell line:A549	10499-107C4	9.55	6.64	4.01	0.69	0.42	0.42	0.00	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	96.52	19.99	7.58	4.14	0.00	2.76	0.00	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	100.84	14.24	7.78	1.32	1.45	0.92	1.05	1.58	0.40
lung, adult, pool1	10019-101D1	272.99	12.17	6.26	1.18	3.78	1.42	1.18	0.12	1.18
lung, fetal, donor1	10068-101I5	163.54	15.98	7.71	2.85	2.00	0.00	0.86	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	134.26	12.37	8.25	1.83	9.62	0.46	0.92	0.92	5.96
lymph node, adult, donor1	10077-102A5	106.98	4.26	4.73	0.47	6.15	0.00	0.47	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	172.71	5.92	4.16	0.00	3.51	1.10	0.00	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	169.49	0.45	0.15	0.30	2.57	0.45	0.00	0.30	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	246.35	16.14	10.19	8.49	1.70	2.55	2.55	3.40	2.55
mature adipocyte, donor1	12231-129F8	61.71	15.54	3.11	1.33	2.66	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	85.29	12.66	4.77	0.21	1.66	0.42	0.83	0.21	0.00
mature adipocyte, donor3	12233-129G1	56.18	9.96	3.32	0.95	1.19	0.47	0.95	0.00	0.00
mature adipocyte, donor4	12234-129G2	24.22	6.58	1.84	0.53	1.32	0.26	1.05	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	78.63	10.25	3.34	0.48	0.71	0.71	0.24	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	19.18	24.82	4.51	0.00	2.26	5.64	2.26	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	58.30	16.37	6.99	2.76	1.47	3.49	5.70	0.92	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	20.97	9.21	3.81	1.59	1.59	1.59	0.95	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	11.09	6.82	1.28	0.43	0.00	3.41	9.38	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	29.70	11.31	7.26	2.70	1.86	2.03	2.36	0.84	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	63.46	14.43	7.00	1.91	1.27	1.06	5.52	0.64	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	7.71	3.85	0.00	0.00	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	43.06	28.71	0.00	0.00	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	14.00	5.03	4.31	1.08	0.00	2.87	3.95	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	25.31	7.79	2.60	0.65	0.65	2.60	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	70.90	14.71	6.35	1.86	1.24	1.70	1.08	1.08	0.31
medulla oblongata, adult, pool1	10038-101F2	75.59	14.20	7.35	1.80	1.22	1.88	0.24	0.98	0.08
medulla oblongata, newborn, donor10223	10361-105F1	38.54	6.94	5.55	1.74	2.08	1.04	0.00	0.69	1.04
medulloblastoma cell line:D283 Med	10838-111E1	6.64	2.88	1.33	0.22	0.22	0.44	0.44	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	39.49	18.95	9.66	2.81	0.49	0.00	0.00	0.49	0.61
melanoma cell line:COLO 679	10514-107E1	43.12	11.93	5.03	1.15	1.01	1.01	0.86	0.14	0.14
melanoma cell line:G-361	10465-106H6	39.09	8.69	2.99	1.63	2.17	0.81	0.81	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	107.10	8.68	2.71	1.99	3.44	0.18	0.90	0.72	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	18.50	9.69	2.64	0.00	0.00	0.00	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	6.48	3.89	3.11	0.00	0.00	0.26	0.26	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.20	17.95	12.27	3.22	0.31	1.23	0.61	0.92	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.00	10.00	4.73	1.27	0.18	1.45	1.09	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.56	7.45	6.21	4.14	0.41	1.24	1.24	1.66	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.49	18.96	12.92	4.21	0.84	1.83	0.56	0.84	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.90	14.44	8.86	5.39	1.35	1.54	1.16	0.96	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	52.75	20.82	15.27	3.47	0.69	2.78	0.00	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	33.64	15.10	7.38	4.63	1.37	3.43	1.03	0.69	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	31.51	16.33	15.18	3.91	1.27	3.22	2.76	1.96	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.31	18.30	11.01	3.85	1.19	2.25	1.46	1.59	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.71	17.69	13.91	3.38	0.41	1.35	1.22	1.76	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	15.93	24.04	14.65	5.55	0.85	0.57	2.42	2.42	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	95.51	10.54	5.93	2.63	2.31	3.29	2.31	1.65	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	37.64	25.60	17.71	9.13	0.55	1.80	2.21	3.18	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.23	11.52	13.27	1.75	1.05	1.75	0.70	0.00	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.90	21.44	16.13	5.92	1.63	0.82	0.61	1.43	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	41.34	15.82	13.66	6.47	2.88	4.31	1.08	2.52	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.66	38.38	27.31	9.41	2.17	1.97	1.34	3.72	1.76
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.10	16.19	13.00	6.38	1.37	2.74	0.68	5.02	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.87	23.50	11.33	6.29	0.00	1.68	1.68	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.81	16.74	9.56	3.59	0.90	1.20	1.94	1.34	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	34.84	28.01	19.08	9.02	1.58	1.84	2.63	2.63	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	47.49	24.67	13.62	2.95	2.21	7.00	1.47	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	36.34	22.03	12.59	6.01	3.43	4.01	0.29	3.15	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.95	11.79	9.26	1.26	0.84	1.26	0.42	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.07	5.48	8.22	3.65	0.46	1.83	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.32	7.16	5.12	2.56	0.51	3.07	0.26	0.77	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	9.16	5.76	1.83	0.52	2.62	0.00	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	6.16	4.93	1.54	0.92	3.70	0.62	1.85	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.47	6.59	6.83	2.12	0.47	3.29	0.47	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.83	7.78	8.46	0.68	1.35	1.02	0.68	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.82	8.25	7.47	0.79	0.00	2.75	0.00	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.44	10.66	6.02	1.39	0.46	2.32	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	18.17	8.36	6.92	1.73	1.15	1.73	1.44	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.52	6.02	6.25	1.56	0.22	2.90	1.12	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.79	9.37	8.89	1.44	0.96	3.61	0.24	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	5.13	11.00	3.67	1.47	2.93	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.46	5.37	9.06	2.69	1.01	2.69	0.67	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.33	6.14	3.68	2.05	0.82	2.87	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.03	6.44	3.44	0.86	0.43	1.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	8.20	5.47	2.73	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	11.37	8.12	5.20	0.97	0.32	1.30	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	7.27	5.82	0.00	0.00	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.73	8.53	7.46	1.07	0.00	2.67	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.00	9.00	3.27	2.45	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.27	4.66	5.05	0.39	0.00	1.94	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	12.59	4.20	0.00	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	3.97	2.98	0.00	0.00	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	6.52	4.74	1.78	1.78	0.59	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	4.87	6.09	2.44	1.22	1.22	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	7.60	1.90	2.53	0.63	1.27	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.28	4.14	2.41	1.38	0.00	1.38	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	2.15	4.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	7.98	3.99	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.19	2.44	0.41	0.81	0.41	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	3.97	2.38	0.00	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.97	5.31	0.59	0.00	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.47	2.81	1.25	0.00	0.00	0.31	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	5.35	1.34	0.00	0.00	1.34	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	3.55	0.00	0.00	0.00	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	2.57	5.14	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	10.33	6.20	0.69	1.38	0.69	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	9.40	5.44	1.48	0.99	0.49	1.48	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	3.36	1.12	0.00	0.00	3.36	0.00	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	6.36	6.36	0.64	0.00	1.27	1.27	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.70	9.67	5.24	1.61	4.84	7.66	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	8.72	10.90	6.54	2.18	8.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	10.14	7.60	2.53	2.53	10.14	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	6.07	3.64	0.00	1.21	3.03	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52	4.52	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	4.94	2.47	0.82	2.47	2.47	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.94	2.38	1.19	0.20	0.40	1.79	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.98	1.62	2.92	0.32	0.97	1.30	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	0.00	0.00	2.04	2.04	3.06	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	99.04	8.51	7.74	0.77	0.00	2.32	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	125.21	17.95	12.05	6.85	2.36	3.78	2.13	3.78	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	85.02	12.05	14.36	8.11	2.32	1.85	1.62	3.71	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	98.29	8.55	17.09	4.27	4.27	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	91.86	10.17	9.97	5.86	1.23	2.88	0.51	4.83	0.72
mesothelioma cell line:Mero-25	10850-111F4	100.31	9.08	8.85	6.81	2.27	1.36	4.77	3.63	0.91
mesothelioma cell line:Mero-41	10851-111F5	59.41	11.25	5.38	0.98	1.47	0.73	1.71	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	36.09	9.96	6.42	1.55	1.55	0.44	0.66	0.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	71.75	6.83	4.47	2.89	2.10	1.31	1.05	1.31	1.05
mesothelioma cell line:Mero-83	10854-111F8	58.73	24.34	17.19	11.40	2.38	3.23	1.53	1.36	0.51
mesothelioma cell line:Mero-84	10855-111F9	31.85	27.05	24.77	6.82	0.25	1.52	1.01	1.52	1.01
mesothelioma cell line:Mero-95	10856-111G1	83.23	19.25	13.46	5.80	2.07	3.31	0.62	1.66	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	22.20	7.45	3.81	1.82	0.33	0.99	0.33	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	65.52	12.13	9.95	7.78	1.45	1.27	1.09	3.44	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	119.75	29.04	24.43	9.40	3.07	4.44	3.25	2.73	0.68
mesothelioma cell line:NCI-H28	10845-111E8	42.50	15.01	5.85	2.29	1.53	1.02	0.51	1.27	0.51
mesothelioma cell line:No36	10857-111G2	30.34	10.11	8.81	3.59	2.61	2.94	1.96	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	124.10	15.72	10.57	6.50	1.08	2.17	4.34	1.08	1.35
migratory langerhans cells, donor1	11901-125F2	83.49	0.38	0.58	0.00	2.11	0.38	0.00	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	175.24	1.10	0.73	0.12	1.34	0.61	0.00	0.12	0.61
migratory langerhans cells, donor3	11903-125F4	164.76	1.08	0.72	0.00	4.13	0.36	0.00	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	77.70	18.94	8.81	3.26	2.61	0.00	3.59	0.33	6.20
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	58.71	9.11	4.45	1.27	1.48	0.42	0.21	0.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.62	11.52	7.83	2.76	1.15	0.46	0.69	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	182.68	3.81	3.04	0.38	1.33	0.76	0.00	0.00	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	90.18	28.83	8.50	1.29	1.66	0.00	0.00	0.18	0.37
myeloma cell line:PCM6	10474-106I6	214.27	11.86	6.92	3.36	3.76	1.98	0.00	2.57	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.74	29.93	7.10	2.03	0.00	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	13.34	5.88	4.12	0.00	0.00	1.57	1.37	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.13	3.57	2.56	1.00	0.33	0.22	0.56	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.18	2.87	2.94	1.03	0.59	0.29	0.29	0.44	0.00
nasal epithelial cells, donor2	12227-129F4	24.84	11.04	5.52	1.66	0.00	3.31	2.76	3.31	0.55
neuroblastoma cell line:CHP-134	10508-107D4	2.99	5.06	1.61	0.23	0.23	0.00	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	20.58	17.59	9.54	2.25	0.19	0.37	0.19	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	14.76	13.29	5.90	1.05	1.48	0.63	1.05	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	12.11	8.01	2.61	0.56	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7.12	10.20	4.27	1.42	0.47	0.24	5.93	0.47	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	16.47	15.20	6.81	1.74	1.11	0.63	9.03	1.27	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	2.21	7.85	2.21	0.81	0.20	0.20	0.60	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	4.45	13.35	5.72	1.27	0.00	0.00	3.18	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	33.00	14.91	7.19	2.40	0.00	1.06	0.27	0.27	1.33
neutrophil PMN, donor1	12133-128D9	223.12	29.75	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56	0.00	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	117.37	7.61	2.71	0.34	1.35	0.51	0.00	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	5.60	4.80	2.40	0.80	0.00	0.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	29.82	10.26	8.98	2.24	0.64	0.00	0.32	0.32	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	148.99	13.66	8.15	2.36	5.26	1.05	0.53	0.79	2.89
nucleus accumbens, adult, pool1	10037-101F1	42.65	23.06	12.94	3.75	0.47	1.87	3.00	1.87	0.09
occipital cortex - adult, donor10196	10172-103C1	12.36	12.36	8.24	0.00	0.00	4.12	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	65.21	21.47	6.98	1.34	1.07	2.15	6.17	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	12.01	4.37	4.73	2.18	0.00	3.64	1.46	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	20.47	13.38	9.97	2.62	3.15	2.62	3.67	0.52	1.31
occipital lobe, fetal, donor1	10073-102A1	8.58	4.29	1.72	0.43	0.86	1.72	0.00	0.43	0.86
occipital pole, adult, pool1	10036-101E9	39.81	19.24	11.27	3.07	0.87	2.92	4.42	1.42	0.47
olfactory region, adult	10195-103E6	35.34	13.95	6.11	2.10	1.15	3.82	2.10	0.57	0.19
optic nerve, donor1	10277-104E7	16.01	8.00	0.00	0.00	0.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	39.64	15.38	11.39	3.30	1.25	0.91	0.34	0.57	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	24.59	11.27	7.56	1.65	0.55	0.00	0.00	0.69	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	137.66	22.01	18.12	5.93	4.23	1.35	0.68	2.88	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	72.89	16.17	8.66	1.62	2.08	0.69	1.62	1.16	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	20.58	16.17	5.59	1.76	0.59	0.59	0.29	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	126.14	12.15	4.67	1.87	0.00	0.00	0.93	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.90	15.06	6.15	2.33	0.85	1.70	0.21	0.64	0.42
ovary, adult, pool1	10020-101D2	107.44	8.82	3.58	1.22	1.31	0.17	1.92	0.17	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	55.91	14.67	8.25	2.93	1.10	2.02	0.37	0.55	0.92
pancreas, adult, donor1	10049-101G4	63.02	12.23	0.94	0.94	1.88	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.31	5.31	2.52	0.00	0.56	0.28	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	205.96	15.33	14.14	5.45	6.13	1.53	2.73	1.87	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	140.58	17.22	12.75	4.14	1.32	1.49	0.33	1.49	0.17
paracentral gyrus, adult, pool1	10035-101E8	37.43	19.59	11.71	3.66	0.46	2.65	4.48	0.92	0.09
parietal cortex, adult, donor10258	10373-105G4	21.29	11.74	4.40	2.20	0.00	2.20	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	22.57	15.05	1.88	1.88	0.00	1.88	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	55.30	17.39	6.56	1.71	1.14	0.86	5.13	0.57	0.29
parietal lobe, adult, pool1	10034-101E7	41.77	18.42	13.48	2.47	1.32	3.08	3.97	0.79	0.09
parietal lobe, fetal, donor1	10072-101I9	7.76	4.85	1.94	1.94	0.97	0.97	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	21.68	5.23	2.99	1.12	1.50	3.74	4.86	0.37	0.37
parotid gland, adult	10199-103F1	94.97	11.10	4.93	0.62	4.93	1.85	0.00	0.00	0.00
penis, adult	10200-103F2	64.45	9.13	4.83	1.07	1.07	1.61	2.15	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	4.09	5.02	2.42	0.93	0.00	0.19	0.56	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	172.21	11.80	5.54	2.62	1.89	1.17	0.29	0.15	2.33
pineal gland - adult, donor10196	10179-103C8	34.83	15.48	7.74	4.52	0.65	1.29	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	79.95	28.43	11.84	4.15	1.78	2.37	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	36.37	7.52	6.27	1.25	2.51	3.76	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	49.58	11.13	3.04	1.01	1.01	3.04	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	90.16	14.59	4.69	1.56	2.08	1.04	3.13	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	36.60	9.36	5.96	1.70	0.00	1.70	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	166.74	8.17	6.99	2.37	1.83	0.54	1.29	0.75	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	203.01	3.31	1.59	0.13	1.46	1.06	0.00	0.40	1.32
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	237.04	17.12	10.12	2.18	3.27	0.93	0.16	0.93	1.87
pons, adult, pool1	10033-101E6	36.23	11.88	9.21	3.79	1.03	1.98	0.95	1.20	0.43
postcentral gyrus, adult, pool1	10032-101E5	36.96	21.45	12.81	3.05	1.22	3.23	4.10	1.13	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	148.49	20.91	6.27	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	54.19	35.83	21.70	5.68	2.77	1.31	0.58	2.04	2.33
prostate cancer cell line:PC-3	10439-106E7	21.78	12.71	9.98	3.63	0.54	1.82	1.82	1.27	0.73
prostate, adult, pool1	10022-101D4	139.67	9.43	3.17	0.73	1.72	0.82	3.45	0.18	0.45
putamen, adult, donor10196	10176-103C5	39.66	25.49	14.16	2.83	0.94	2.36	1.18	2.12	0.47
putamen, adult, donor10252	10152-102I8	33.33	19.61	1.96	5.88	0.00	0.00	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	7.65	0.00	3.28	0.00	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	31.41	21.50	13.05	3.38	0.00	2.66	1.93	0.48	0.00
putamen, newborn, donor10223	10365-105F5	20.24	4.50	0.00	0.75	1.50	1.50	1.50	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	56.15	5.24	4.07	0.87	0.29	0.87	0.58	0.87	0.00
rectum, fetal, donor1	10067-101I4	45.90	13.91	2.78	0.00	0.00	0.00	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	96.67	15.26	7.42	1.48	0.42	0.42	0.42	0.85	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	599.36	4.14	3.31	1.66	8.70	0.41	0.41	0.41	14.91
retina, adult, pool1	10030-101E3	101.98	13.22	9.34	2.09	0.89	0.60	1.69	0.20	0.20
retinoblastoma cell line:Y79	10475-106I7	0.26	1.30	1.04	0.00	0.00	0.00	0.00	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	42.91	21.02	16.23	7.50	0.49	0.61	1.72	1.97	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	9.56	6.75	3.66	0.56	0.00	0.28	0.28	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.23	8.34	4.55	1.52	0.00	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	36.74	12.62	8.58	3.08	1.29	3.24	2.75	2.59	0.97
salivary acinar cells, donor2	11772-123I8	35.94	8.81	5.09	1.79	1.38	2.34	2.34	0.41	0.28
salivary acinar cells, donor3	11773-123I9	47.67	7.28	1.99	0.66	1.32	2.65	1.99	0.00	0.00
salivary gland, adult, pool1	10093-102C3	124.69	13.15	5.15	1.14	1.72	0.00	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.86	6.83	4.81	1.94	0.67	0.76	0.93	0.34	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	7.76	5.76	4.58	1.88	0.71	0.94	0.94	0.12	0.24
seminal vesicle, adult	10201-103F3	102.64	8.99	5.29	1.06	2.12	1.06	1.59	0.00	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	162.52	9.23	10.93	5.10	2.43	1.94	7.53	0.73	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	108.71	12.83	9.31	2.77	4.28	3.27	5.03	2.52	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	48.17	16.06	13.05	6.02	3.01	0.00	0.00	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	112.69	5.64	3.22	0.81	1.61	0.27	1.34	0.40	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	57.36	6.30	5.75	0.66	0.55	0.44	0.22	0.33	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	59.87	10.84	5.68	1.42	0.90	0.52	0.39	0.39	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	28.37	4.26	2.13	0.00	0.71	0.00	0.00	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	113.94	9.00	4.44	0.48	2.52	0.24	1.08	0.12	0.36
skeletal muscle, fetal, donor1	10066-101I3	28.14	6.03	3.02	0.00	3.02	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	0.00	20.36	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	57.44	14.52	6.94	1.89	1.26	1.26	1.26	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	21.01	18.01	11.34	2.00	0.33	0.00	0.00	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.83	10.40	5.67	1.26	0.32	0.63	0.32	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	12.53	8.67	0.96	0.19	0.96	1.16	0.19	0.00	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	5.93	2.14	0.33	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.16	0.00	0.00	0.00	0.00	0.16	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	91.74	12.64	6.10	1.09	1.31	0.44	0.00	0.44	0.65
small intestine, adult, pool1	10024-101D6	379.11	11.47	9.32	2.75	16.12	0.84	3.22	0.84	1.55
small intestine, fetal, donor1	10064-101I1	197.54	9.58	7.13	1.23	8.11	1.47	0.98	0.00	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	69.24	8.72	4.62	1.54	4.10	1.03	0.51	0.51	2.56
smooth muscle, adult, pool1	10048-101G3	43.68	10.34	2.07	0.00	1.03	0.26	0.52	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	18.49	9.92	8.04	1.34	0.27	0.80	0.54	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	28.91	6.88	1.61	0.00	1.15	1.38	1.15	0.23	0.92
spinal cord, adult, donor10252	10159-103A6	68.21	6.31	2.76	0.39	0.00	0.39	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	20.06	5.53	2.08	0.00	0.69	1.38	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	63.42	16.47	10.98	0.61	3.05	1.83	1.83	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	38.57	5.97	4.13	1.38	1.38	1.38	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.28	12.84	9.71	3.73	0.30	2.24	0.30	0.90	0.15
spleen, adult, pool1	10025-101D7	300.89	4.52	4.30	1.21	5.40	0.33	2.42	0.33	1.32
spleen, fetal, pool1	10044-101F8	216.59	6.59	4.05	1.43	2.70	0.48	5.09	0.56	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	270.48	2.59	1.86	0.31	2.28	0.41	0.00	0.31	1.55
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	148.10	10.63	6.46	0.57	0.95	0.57	0.57	1.14	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	79.68	18.52	10.83	2.45	2.45	0.70	0.70	1.75	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	56.69	19.94	17.59	7.04	1.17	1.95	2.35	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	66.86	9.34	6.30	1.58	0.56	1.13	1.24	0.79	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	26.26	9.74	2.54	0.42	1.27	0.85	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	51.19	25.81	13.54	4.23	1.27	3.38	0.42	0.42	1.27
stomach, fetal, donor1	10062-101H8	70.49	12.82	4.27	0.00	1.07	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	163.50	13.67	7.98	1.71	3.99	0.00	0.57	0.57	2.85
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	67.30	9.35	4.15	1.04	0.42	0.21	0.62	0.00	0.42
substantia nigra, adult, donor10258	10371-105G2	13.97	6.21	0.52	1.55	0.00	0.52	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	30.38	4.24	0.71	0.71	0.71	2.12	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	25.68	16.05	6.88	3.21	0.69	1.60	0.00	1.83	0.23
temporal lobe, adult, pool1	10031-101E4	51.37	20.60	14.50	4.15	1.53	2.46	4.83	0.85	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	8.55	3.56	1.42	1.42	0.71	1.42	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.55	10.55	1.76	0.00	0.88	1.32	0.00	0.44	0.44
tenocyte, donor1	11763-123H8	51.67	20.60	11.17	3.49	0.35	1.40	1.05	0.00	1.75
tenocyte, donor2	11765-123I1	59.13	11.83	5.72	0.76	1.14	1.53	0.38	0.76	0.00
tenocyte, donor3	11768-123I4	17.05	11.12	7.04	2.97	0.74	1.48	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1.19	0.51	0.68	0.00	0.00	0.00	0.00	0.00	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	1.08	3.70	1.08	1.08	0.31	0.00	0.00	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	5.89	4.49	2.17	0.46	0.31	0.00	0.00	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.33	2.03	1.02	0.13	0.76	0.38	0.25	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	2.27	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.98	2.29	0.44	0.22	0.76	0.22	0.76	0.22	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.98	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	91.91	13.21	10.20	3.97	2.58	0.54	2.04	0.32	0.54
testis, adult, pool2	10096-102C6	24.36	9.47	7.22	1.80	0.90	0.90	0.90	0.00	0.00
thalamus - adult, donor10196	10168-103B6	24.29	5.52	3.31	0.00	0.00	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	65.95	10.31	6.41	0.78	1.72	0.94	1.25	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	6.16	3.08	1.54	0.00	9.24	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	22.07	4.61	3.29	1.32	1.98	1.48	0.49	0.16	0.66
thalamus, newborn, donor10223	10366-105F6	10.36	5.18	2.88	2.88	6.33	4.60	0.00	1.15	0.58
throat, adult	10209-103G2	84.89	8.49	5.74	0.50	3.25	0.50	1.50	0.25	1.00
throat, fetal, donor1	10061-101H7	44.49	5.48	5.18	0.91	1.22	0.91	0.30	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	33.39	15.30	5.56	0.60	0.79	1.19	1.59	0.20	0.60
thymus, adult, pool1	10027-101D9	393.98	11.13	5.47	1.49	5.96	0.60	0.20	0.30	2.09
thymus, fetal, pool1	10043-101F7	232.54	7.59	4.05	1.04	2.39	0.94	0.42	0.10	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	94.00	21.01	11.83	3.06	1.73	1.99	0.40	0.40	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	44.56	14.53	5.87	1.96	0.84	0.70	0.56	0.28	0.00
thyroid, adult, pool1	10028-101E1	298.97	11.48	4.39	0.75	2.61	1.12	2.33	0.09	0.37
thyroid, fetal, donor1	10060-101H6	88.85	8.17	4.75	0.53	2.37	1.05	0.53	0.79	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	76.99	12.32	0.00	3.08	9.24	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	91.40	7.91	8.61	1.86	3.95	1.16	0.47	0.23	0.93
tongue, fetal, donor1	10059-101H5	34.68	10.64	5.91	0.39	1.97	0.00	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	276.69	8.92	7.11	2.00	2.00	0.90	0.50	0.40	0.90
trachea, adult, pool1	10029-101E2	165.23	9.49	6.22	2.78	2.70	1.39	1.64	0.49	0.49
trachea, fetal, donor1	10058-101H4	57.70	15.39	3.85	1.54	3.46	0.77	1.54	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.03	12.40	12.05	1.06	1.42	2.83	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	96.66	6.48	4.96	1.52	1.01	0.30	0.20	0.51	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	128.48	11.75	6.11	1.25	2.98	1.88	1.41	1.41	2.19
tridermal teratoma cell line:HGRT	10694-109G1	45.66	5.71	5.71	0.00	0.00	1.90	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	72.29	13.04	6.94	2.71	1.10	0.93	0.76	0.59	0.76
umbilical cord, fetal, donor1	10057-101H3	41.73	10.43	4.17	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	65.01	10.75	4.10	1.02	0.51	0.51	5.12	0.34	0.34
uterus, fetal, donor1	10055-101H1	30.72	18.43	3.07	0.00	0.51	0.51	2.56	0.00	0.00
vagina, adult	10204-103F6	62.68	5.82	0.65	0.00	0.65	0.00	1.29	0.65	0.00
vein, adult	10191-103E2	211.31	9.21	3.73	0.44	3.73	1.32	0.66	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	217.10	1.34	1.87	0.53	1.60	1.07	0.00	0.27	1.87

Property "Nearest transcripts" (as page type) with input value "ENST00000437116.2:-281 EU693375:-281 AF314222:-281 HQ447577:-282 CU687344:-282 ENST00000480730.5:-289 AF067286:-289 AB010639:-294 AF009510:-297 ENST00000434618.7:-318 NM_003190.5:-318 NM_172209.3:-318 NM_172208.3:-318 AF029750:-319 LF341208:-346 MA576785:-346 Y13582:-410 ENST00000426633.6:-452 BC010279:-452 BC080574:-452 ENST00000467025.1:-455 BC064966:-484 ENST00000475304.5:-491 ENST00000489157.5:-494 AK297903:-494" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.